CASEID,PRIMARYID,CASEVERSION,I_F_CODE,EVENT_DT,MFR_DT,INIT_FDA_DT,FDA_DT,REPT_COD,AUTH_NUM,MFR_NUM,MFR_SNDR,LIT_REF,AGE,AGE_COD,AGE_GRP,SEX,E_SUB,WT,WT_COD,REPT_DT,TO_MFR,OCCP_COD,REPORTER_COUNTRY,OCCR_COUNTRY,DRUGNAME,PT,PRIMARYID_OUTC,OUTC_COD,PRIMARYID_RPSR,RPSR_COD,PRIMARYID_THER,DSG_DRUG_SEQ,START_DT,END_DT,DUR,DUR_COD,PRIMARYID_INDI,INDI_DRUG_SEQ,INDI_PT
10417589,104175892,2,F,,20230530,20140829,20230614,EXP,,US-CIPLA LTD.-2014ZA01186,CIPLA,"LiuKC,FarahaniM,MashambaT,MawelaM,JosephJ,SchaikNV,HoneyE,GillM,JassatW,StringerEM,ChintuN,MarlinkRG. Pregnancy outcomes and birth defects from an antiretroviral drug safety study of women in South Africa and Zambia. AIDS. 2014;28",,,,,Y,,,20230614,,HP,US,ZA,EFAVIRENZ,Blepharophimosis;Eyelid ptosis,104175892,CA,,,,,,,,,104175892,1,Antiretroviral therapy
10592382,105923822,2,F,,20230530,20141119,20230613,EXP,,NL-CIPLA LTD.-2014NL01965,CIPLA,"Rokx C, Fibriani A, David A. M. C.,Vijver VD,Verbon A,Schutten M, Gras L, Rijnders BJA,. Increased Virological Failure in Naive HIV 1 Infected Patients Taking Lamivudine Compared With Emtricitabine in Combination With Tenofovir and Efavirenz or Nevirapine in the Dutch Nationwide ATHENA Cohort. HIV/AIDS. 2014;1 to 11",,,,,Y,,,20230613,,MD,NL,NL,EFAVIRENZ,Gene mutation;Virologic failure,105923822,OT,,,,,,,,,105923822,1,HIV infection
11322615,113226153,3,F,,20230417,20150730,20230428,EXP,,ZA-CIPLA LTD.-2015ZA06047,CIPLA,"Anne Derache, Carole L. Wallis, Saran Vardhanabhuti, John Bartlett, Nagalingeswaran Kumarasamy, David Katzenstein. Phenotype, Genotype and Drug Resistance in Subtype C HIV-1 Infection. 1 to 26",,,,,Y,,,20230428,,HP,ZA,ZA,EFAVIRENZ,Drug resistance;Gene mutation;Treatment failure,113226153,OT,,,,,,,,,113226153,1,HIV infection
14462981,1446298118,18,F,,20230323,20180130,20230403,EXP,,GB-ALLERGAN-1771124US,ALLERGAN,,,,,M,Y,,,20230403,,MD,GB,GB,EFAVIRENZ,Drug interaction;Renal impairment,1446298118,OT,,,1446298118,5,,,152,DAY,1446298118,1,Inflammatory bowel disease
15114149,1511414949,49,F,20100629,20230524,20180706,20230601,EXP,,GB-AUROBINDO-AUR-APL-2018-033634,AUROBINDO,,3,MON,,M,Y,,,20230601,,MD,GB,GB,EFAVIRENZ,Abortion spontaneous;Alanine aminotransferase increased;Alopecia;Anaemia;Aspartate aminotransferase increased;Caesarean section;Cleft lip and palate;Device related infection;Diarrhoea;Ejection fraction decreased;Epistaxis;Exposure during pregnancy;Fatigue;Foetal exposure during pregnancy;Gastrooesophageal reflux disease;Gingival swelling;Hepatic cytolysis;Hot flush;Hydrops foetalis;Influenza like illness;Intentional product use issue;Lymphoedema;Maternal exposure during pregnancy;Mucosal inflammation;Off label use;Osteonecrosis of jaw;Rash;Sepsis;Trisomy 18;Ultrasound antenatal screen;Vascular device infection,1511414949,CA,,,1511414949,1,20171006,20180205,4,MON,1511414949,1,HIV infection
15115814,1511581453,53,F,20100629,20230613,20180706,20230621,EXP,,GB-MYLANLABS-2018M1048354,MYLAN,,3,MON,,M,Y,,,20230621,,HP,GB,GB,EFAVIRENZ,Abortion spontaneous;Alanine aminotransferase increased;Aspartate aminotransferase increased;Caesarean section;Cleft lip and palate;Drug abuse;Exposure during pregnancy;Foetal exposure during pregnancy;Hepatic cytolysis;Hydrops foetalis;Intentional product use issue;Maternal exposure during pregnancy;Off label use;Trisomy 18;Ultrasound antenatal screen,1511581453,OT,,,1511581453,9,20090101,20180205,241,DAY,1511581453,1,HIV infection
15158165,1515816551,51,F,20100629,20230524,20180718,20230526,EXP,,GB-AUROBINDO-AUR-APL-2018-036078,AUROBINDO,,43,YR,,F,Y,43,KG,20230526,,MD,GB,GB,EFAVIRENZ;EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Abortion spontaneous;Alanine aminotransferase increased;Aspartate aminotransferase increased;Caesarean section;Cleft lip and palate;Drug abuse;Exposure during pregnancy;Foetal exposure during pregnancy;Hepatic cytolysis;Hydrops foetalis;Intentional product use issue;Maternal exposure during pregnancy;Off label use;Trisomy 18;Ultrasound antenatal screen,1515816551,CA,,,1515816551,1,20100610,20180205,4,MON,1515816551,1,HIV infection
15363025,1536302522,22,F,20171006,20220927,20180907,20230626,EXP,GB-EMA-DD-20180827-KSEVHUMANWT-125137,GB-NOVOPROD-619421,NOVO NORDISK,,3,MON,,M,Y,,,20230626,,HP,GB,GB,EFAVIRENZ,Alanine aminotransferase increased;Aspartate aminotransferase increased;Cleft lip and palate;Foetal exposure during pregnancy;Hepatic cytolysis;Hydrops foetalis;Intentional product use issue;Off label use;Trisomy 18;Ultrasound antenatal screen,1536302522,DE,,,1536302522,1,20180205,20180205,122,DAY,1536302522,1,HIV infection
15651977,156519774,4,F,20130801,20230429,20181123,20230504,EXP,,US-GILEAD-2018-0375835,GILEAD,,43,YR,A,M,Y,117.01,KG,20230504,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Economic problem;Emotional distress;Foot fracture;Osteoporosis;Pain;Spinal compression fracture,156519774,OT,,,156519774,1,2001,2012,2,YR,156519774,1,HIV infection
15652214,156522143,3,F,20160401,20230429,20181123,20230503,PER,,US-GILEAD-2018-0376074,GILEAD,,54,YR,A,F,Y,107.48,KG,20230503,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Economic problem;Emotional distress;Loss of personal independence in daily activities;Osteopenia;Pain,,,,,156522143,1,2001,2004,,,156522143,1,HIV infection
15656869,156568693,3,F,20141201,20230401,20181126,20230407,PER,,US-GILEAD-2018-0376047,GILEAD,,61,YR,A,F,Y,120.64,KG,20230407,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Back pain;Chronic kidney disease;Economic problem;Emotional distress;Pain;Renal pain,156568693,OT,,,156568693,1,2004,201302,,,156568693,1,HIV infection
15661710,156617106,6,F,20100101,20230413,20181127,20230418,EXP,,US-GILEAD-2018-0376139,GILEAD,,38,YR,A,M,Y,89.796,KG,20230418,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Economic problem;Emotional distress;Off label use;Pain,156617106,OT,,,156617106,1,2010,2013,,,156617106,1,HIV infection
16020890,1602089023,23,F,,20230529,20190301,20230606,EXP,,CA-AUROBINDO-AUR-APL-2019-010743,AUROBINDO,,54,YR,,M,Y,,,20230606,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Incorrect route of product administration;Intentional product use issue;Loss of personal independence in daily activities;Prescribed overdose;Product use in unapproved indication,1602089023,DE,,,,,,,,,1602089023,1,HIV infection
16064738,1606473856,56,F,20100629,20230405,20190312,20230410,EXP,,GB-MYLANLABS-2019M1022917,MYLAN,,43,YR,,F,Y,43,KG,20230410,,HP,GB,GB,EFAVIRENZ,Abortion spontaneous;Alanine aminotransferase increased;Aspartate aminotransferase increased;Caesarean section;Cleft lip and palate;Drug abuse;Foetal exposure during pregnancy;Hepatic cytolysis;Hydrops foetalis;Intentional product use issue;Maternal exposure during pregnancy;Off label use;Trisomy 18;Ultrasound antenatal screen,1606473856,CA,,,1606473856,13,20171006,20180205,4,MON,1606473856,1,Product used for unknown indication
16081155,1608115510,10,F,,20230417,20190316,20230428,EXP,,CA-AUROBINDO-AUR-APL-2019-013363,AUROBINDO,,54,YR,,M,Y,,,20230428,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,1608115510,HO,,,,,,,,,1608115510,1,HIV infection
16206633,162066334,4,F,,20230418,20190417,20230502,EXP,,CA-AUROBINDO-AUR-APL-2019-019815,AUROBINDO,,,,,M,Y,,,20230502,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction,162066334,OT,,,,,,,,,162066334,1,Product used for unknown indication
16340534,163405346,6,F,,20230418,20190522,20230430,EXP,,CA-AUROBINDO-AUR-APL-2019-027585,AUROBINDO,,54,YR,,M,Y,,,20230429,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,163405346,OT,,,,,,,,,163405346,1,HIV infection
16342541,163425413,3,F,20110101,20230411,20190522,20230413,EXP,,US-GILEAD-2019-0407993,GILEAD,,59,YR,A,F,Y,78.912,KG,20230413,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone loss;Depression;Economic problem;Emotional distress;General physical health deterioration;Hip arthroplasty;Osteopenia;Osteoporosis;Pain;Quality of life decreased,163425413,OT,,,163425413,1,2004,20161012,,,163425413,1,HIV infection
16349775,163497753,3,F,20140701,20230412,20190523,20230413,PER,,US-GILEAD-2019-0408303,GILEAD,,55,YR,A,F,Y,78.005,KG,20230413,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Emotional distress;Osteopenia;Pain,,,,,163497753,1,2005,2010,,,163497753,1,HIV infection
16443892,164438924,4,F,,20230607,20190618,20230617,EXP,,CA-AUROBINDO-AUR-APL-2019-033424,AUROBINDO,,44,YR,,M,Y,,,20230617,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor retardation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,164438924,HO,,,164438924,16,,,355,DAY,164438924,1,Psychotic disorder
16542961,165429616,6,F,,20230417,20190709,20230430,EXP,,CA-AUROBINDO-AUR-APL-2019-037761,AUROBINDO,,54,YR,,M,Y,,,20230429,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,165429616,HO,,,,,,,,,165429616,1,HIV infection
16549483,165494836,6,F,,20230417,20190710,20230430,EXP,,CA-AUROBINDO-AUR-APL-2019-037892,AUROBINDO,,54,YR,,M,Y,,,20230429,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Intentional product use issue;Loss of personal independence in daily activities;Prescribed overdose,165494836,DE,,,,,,,,,165494836,1,HIV infection
16597483,165974838,8,F,20080101,20230621,20190719,20230626,PER,,US-GILEAD-2019-0418455,GILEAD,,52,YR,A,M,Y,,,20230626,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Arthritis;Back pain;Bone density decreased;Bone loss;Cervical radiculopathy;Cervical spinal stenosis;Depression;Drug ineffective;Economic problem;Emotional distress;Hip fracture;Intervertebral disc degeneration;Intervertebral disc operation;Mobility decreased;Multiple fractures;Osteonecrosis;Osteopenia;Osteoporotic fracture;Pain;Pathological fracture;Sacroiliac joint dysfunction;Spinal column injury;Spinal osteoarthritis;Spinal stenosis;Tooth fracture,165974838,OT,,,165974838,1,2004,2013,1706,DAY,165974838,1,HIV infection
16623707,166237076,6,F,20120615,20230622,20190724,20230627,EXP,,US-GILEAD-2019-0419555,GILEAD,,56,YR,A,M,Y,57.2,KG,20230627,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Back pain;Chronic kidney disease;Condition aggravated;Economic problem;Emotional distress;Glomerulonephritis;Haematuria;Intervertebral disc degeneration;Neck pain;Nephropathy;Osteoarthritis;Osteopenia;Pain;Pain in extremity;Proteinuria;Renal cyst;Renal failure;Scoliosis;Spinal disorder;Spinal pain,166237076,OT,,,166237076,1,2006,2018,,,166237076,1,HIV infection
16758574,167585744,4,F,20130101,20230506,20190830,20230516,EXP,,US-GILEAD-2019-0425696,GILEAD,,55,YR,A,M,Y,,,20230516,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Arthritis;Blood creatinine increased;Bone loss;Chronic kidney disease;Dental caries;Economic problem;Emotional distress;Oral disorder;Osteoporotic fracture;Pain,167585744,OT,,,167585744,1,20060615,2019,3294,DAY,167585744,1,HIV infection
16802468,168024682,2,F,,20230421,20190912,20230424,EXP,,ES-ABBVIE-19P-144-2915335-00,ABBVIE,"Kwon M, Bailen R, Balsalobre P, Jurado M, Bermudez A, Badiola J, et al.. Allogeneic stem-cell transplantation in HIV-1-infected patients with high-risk hematological disorders.. AIDS. 2019;33(9):1441-1447.",,,A,,Y,,,20230424,,MD,ES,ES,EFAVIRENZ,Blood HIV RNA;Disseminated tuberculosis;Drug interaction;Hepatotoxicity;Neurotoxicity,168024682,OT,,,168024682,1,2008,,,,168024682,1,HIV infection
16832095,168320959,9,F,,20230601,20190920,20230609,EXP,,ES-AUROBINDO-AUR-APL-2019-060571,AUROBINDO,"Kwon M, Bailen R, Balsalobre P, Jurado M, Bermudez A, Badiola J et.. Allogeneic stem-cell transplantation in HIV-1-infected patients with high-risk hematological disorders. AIDS. 2019;33(9):1441-1447",,,A,,Y,,,20230609,,MD,ES,ES,EFAVIRENZ;EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Blood HIV RNA;Disseminated tuberculosis;Drug interaction;Hepatotoxicity;Neurotoxicity,168320959,OT,,,168320959,1,2008,,,,168320959,1,Antiretroviral therapy
16843822,168438222,2,F,20161101,20230429,20190924,20230505,EXP,,US-GILEAD-2019-0429585,GILEAD,,61,YR,A,M,Y,,,20230505,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Death;Decreased activity;Depression;Economic problem;Emotional distress;Loss of personal independence in daily activities;Multiple injuries;Quality of life decreased,168438222,OT,,,168438222,1,20090822,20141017,1882,DAY,168438222,1,HIV infection
16844259,168442593,3,F,20190822,20230421,20190924,20230424,PER,,US-GILEAD-2019-0429219,GILEAD,,54,YR,A,F,Y,58.957,KG,20230424,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Economic problem;Emotional distress;Osteopenia;Pain,,,,,168442593,1,2001,2018,,,168442593,1,HIV infection
16844478,168444783,3,F,20080101,20230421,20190924,20230425,EXP,,US-GILEAD-2019-0429687,GILEAD,,29,YR,A,M,Y,65.76,KG,20230425,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Blood creatinine increased;Bone density decreased;Decreased activity;Depression;Economic problem;Emotional distress;End stage renal disease;Hyperlipidaemia;Insomnia;Loss of personal independence in daily activities;Osteoporosis;Pain;Quality of life decreased;Renal disorder;Renal failure;Renal impairment,168444783,OT,,,168444783,1,2001,2008,,,168444783,1,HIV infection
16845382,168453823,3,F,20150301,20230411,20190924,20230413,EXP,,US-GILEAD-2019-0429703,GILEAD,,51,YR,A,M,Y,84.807,KG,20230413,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Decreased activity;Depression;Emotional distress;Fatigue;Mobility decreased;Osteoporosis;Pain;Quality of life decreased;Renal impairment,168453823,OT,,,168453823,1,2002,20181002,,,168453823,1,HIV infection
16855931,168559313,3,F,20140601,20230406,20190926,20230411,EXP,,US-GILEAD-2019-0429827,GILEAD,,28,YR,A,M,Y,97.959,KG,20230411,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Decreased activity;Emotional distress;End stage renal disease;Fatigue;Illness;Loss of personal independence in daily activities;Mobility decreased;Pain;Quality of life decreased;Vomiting,168559313,HO,,,168559313,1,2006,2014,,,168559313,1,HIV infection
16856454,168564544,4,F,20120101,20230404,20190926,20230407,EXP,,US-GILEAD-2019-0429624,GILEAD,,23,YR,A,M,Y,72.562,KG,20230407,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Death;Decreased activity;Emotional distress;Fear;Impaired work ability;Loss of personal independence in daily activities;Pain;Quality of life decreased;Renal failure;Renal injury;Skeletal injury,168564544,HO,,,168564544,1,2008,2013,1080,DAY,168564544,1,HIV infection
16856482,168564823,3,F,20181201,20230403,20190926,20230407,EXP,,US-GILEAD-2019-0429730,GILEAD,,60,YR,A,M,Y,,,20230407,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Back pain;Blood creatinine increased;Chronic kidney disease;Economic problem;Emotional distress;Fatigue;Loss of personal independence in daily activities;Pain;Quality of life decreased;Renal impairment;Urinary tract infection,168564823,HO,,,168564823,1,2014,201903,,,168564823,1,HIV infection
16857423,168574233,3,F,20100101,20230331,20190926,20230406,EXP,,US-GILEAD-2019-0429293,GILEAD,,42,YR,A,F,Y,176.87,KG,20230406,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Arthritis;Arthropathy;Bone density decreased;Economic problem;Emotional distress;Gait disturbance;Loss of personal independence in daily activities;Mobility decreased;Osteoporosis;Pain,168574233,OT,,,168574233,1,2009,2016,,,168574233,1,HIV infection
16858997,168589974,4,F,20070501,20230511,20190926,20230516,EXP,,US-GILEAD-2019-0429671,GILEAD,,43,YR,A,M,Y,,,20230515,,LW,US,US,SUSTIVA,Anaemia;Anhedonia;Anxiety;Decreased activity;Emotional distress;End stage renal disease;Fatigue;Nephrogenic anaemia;Pain;Quality of life decreased;Renal failure;Renal tubular necrosis,168589974,HO,,,168589974,1,20070409,200806,96,DAY,168589974,1,HIV infection
16970346,169703468,8,F,20080101,20230626,20191029,20230629,EXP,,US-GILEAD-2019-0434731,GILEAD,,41,YR,A,F,Y,57.143,KG,20230629,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Back pain;Bone density decreased;Depression;Economic problem;Emotional distress;Fanconi syndrome acquired;Fatigue;Glycosuria;Osteopenia;Osteoporosis;Pain;Pathological fracture;Proteinuria;Renal failure;Vitamin D decreased;Weight decreased,169703468,OT,,,169703468,1,2001,2010,3261,DAY,169703468,1,HIV infection
16978043,169780436,6,F,20060101,20230503,20191031,20230505,EXP,,US-GILEAD-2019-0434706,GILEAD,,42,YR,A,M,Y,,,20230505,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Back pain;Bone density decreased;Bone loss;Economic problem;Emotional distress;Foot fracture;Fracture;Osteoporosis;Osteoporotic fracture;Pain,169780436,OT,,,169780436,1,2002,2005,,,169780436,1,HIV infection
17017670,170176707,7,F,,20230425,20191111,20230508,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-081449,BRISTOL MYERS SQUIBB,"Kwon M, Bailen R, Balsalobre P, Jurado M, Bermudez A, Badiola J, et al. Allogenic stem-cell transplantation in HIV-1-infected patients with high-risk hematological disorders. AIDS. 2019;33(9):1441-7. doi:10.1097/QAD.0000000000002209.",,,A,,Y,,,20230508,,MD,ES,ES,EFAVIRENZ,Disseminated tuberculosis;Drug interaction;Hepatotoxicity;Neurotoxicity,170176707,OT,,,170176707,1,2008,,,,170176707,1,Antiretroviral therapy
17044956,1704495613,13,F,,20230517,20191118,20230519,EXP,,CA-BAUSCH-BL-2019-058588,BAUSCH AND LOMB,"Harris M, Larsen G, Montaner J. Exacerbation of depression associated with starting raltegravir: a report of four cases. AIDS. 2008;22 (14):1890-1892. doi:10.1097/QAD.0b013e32830e0169",54,YR,,M,Y,,,20230519,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,1704495613,DE,,,,,,,,,1704495613,1,Bipolar disorder
17220559,172205597,7,F,,20230609,20191231,20230614,EXP,,ES-MYLANLABS-2019M1132018,MYLAN,"Kwon M, Bailen R, Balsalobre P, Jurado M, Bermudez A, Badiola J, et al.. Allogeneic stem-cell transplantation in HIV-1-infected patients with high-risk hematological disorders. AIDS. 2019;33(9):1441-1447",,,A,,Y,,,20230614,,MD,ES,ES,EFAVIRENZ;EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Blood HIV RNA;Disseminated tuberculosis;Drug interaction;Hepatotoxicity;Neurotoxicity,172205597,OT,,,172205597,1,2008,,,,172205597,1,HIV infection
17222608,172226085,5,F,20120521,20230602,20200102,20230615,EXP,,GB-IPCA LABORATORIES LIMITED-IPC-2019-GB-002333,IPCA,,,,,,Y,,,20230615,,HP,GB,GB,EFAVIRENZ,Abortion spontaneous;Alanine aminotransferase increased;Aspartate aminotransferase increased;Cleft lip and palate;Drug abuse;Exposure during pregnancy;Foetal exposure during pregnancy;Hepatic cytolysis;Hydrops foetalis;Intentional product use issue;Maternal exposure during pregnancy;Off label use;Trisomy 18;Ultrasound antenatal screen,172226085,CA,,,172226085,2,20171006,20180205,123,DAY,172226085,1,Product used for unknown indication
17244373,172443737,7,F,20151109,20230502,20200107,20230504,EXP,,US-GILEAD-2020-0445052,GILEAD,,50,YR,A,M,Y,64.863,KG,20230504,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Chronic kidney disease;Economic problem;Emotional distress;Hip fracture;Multiple fractures;Nephrolithiasis;Osteoporosis;Pain,172443737,OT,,,172443737,1,201208,201610,1225,DAY,172443737,1,HIV infection
17291227,172912276,6,F,20070101,20230522,20200121,20230524,EXP,,US-GILEAD-2020-0447101,GILEAD,,54,YR,A,M,Y,74.376,KG,20230524,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density abnormal;Bone density decreased;Economic problem;Emotional distress;Fanconi syndrome acquired;Hip fracture;Multiple fractures;Nephrolithiasis;Osteomalacia;Osteopenia;Osteoporotic fracture;Pain;Renal cyst;Tooth loss;Wrist fracture,172912276,OT,,,172912276,1,200510,20060203,732,DAY,172912276,1,HIV infection
17313822,173138224,4,F,20140101,20230511,20200124,20230516,EXP,,US-GILEAD-2020-0448025,GILEAD,,,,A,M,Y,104.3,KG,20230516,,LW,US,US,EFAVIRENZ;SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Depression;Disturbance in attention;Eating disorder;Economic problem;Emotional distress;End stage renal disease;Fatigue;Pain;Renal disorder;Renal failure;Sexual dysfunction;Sleep apnoea syndrome;Sleep disorder,173138224,OT,,,173138224,1,20120209,201601,26,DAY,173138224,1,HIV infection
17350813,173508133,3,F,20070101,20230411,20200130,20230414,EXP,,US-GILEAD-2020-0448710,GILEAD,,,,A,M,Y,99.773,KG,20230414,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Bone density decreased;Chronic kidney disease;Comminuted fracture;Depression;Economic problem;Emotional distress;Osteopenia;Osteoporosis;Pain,173508133,OT,,,173508133,1,2006,2009,,,173508133,1,HIV infection
17353480,173534804,4,F,20110101,20230516,20200131,20230519,EXP,,US-GILEAD-2020-0448802,GILEAD,,,,A,F,Y,,,20230519,,LW,US,US,SUSTIVA,Anaemia;Anhedonia;Anxiety;Chronic kidney disease;Economic problem;Emotional distress;End stage renal disease;Pain;Renal failure,173534804,OT,,,173534804,1,2004,,,,173534804,1,HIV infection
17359915,173599153,3,F,20141007,20230509,20200203,20230513,EXP,,US-GILEAD-2020-0448758,GILEAD,,53,YR,A,F,Y,71.655,KG,20230513,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Bone loss;Economic problem;Emotional distress;Gait inability;Osteopenia;Osteoporosis;Pain,173599153,OT,,,173599153,1,2009,20170221,,,173599153,1,HIV infection
17362144,173621443,3,F,20170101,20230414,20200203,20230419,EXP,,US-GILEAD-2020-0448814,GILEAD,,,,A,F,Y,98,KG,20230419,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Death;Economic problem;Emotional distress;Foot fracture;Gait disturbance;Osteoporosis;Pain;Pelvic fracture;Upper limb fracture,173621443,DE,,,173621443,1,2004,201605,,,173621443,1,HIV infection
17412129,174121296,6,F,20140101,20230616,20200213,20230621,EXP,,US-GILEAD-2020-0450637,GILEAD,,51,YR,A,M,Y,86.2,KG,20230621,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Arthralgia;Bone density decreased;Economic problem;Emotional distress;Joint destruction;Mobility decreased;Osteopenia;Pain;Spinal osteoarthritis,174121296,OT,,,174121296,1,201312,20170412,,,174121296,1,HIV infection
17484391,174843919,9,F,20090901,20230519,20200302,20230523,EXP,,US-GILEAD-2020-0452915,GILEAD,,51,YR,A,M,Y,88.435,KG,20230523,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Cerebral haemorrhage;Condition aggravated;Economic problem;Emotional distress;Fear of falling;Loss of personal independence in daily activities;Nephrolithiasis;Osteopenia;Osteoporosis;Pain;Physical disability;Renal impairment;Tooth fracture;Tooth loss,174843919,OT,,,174843919,1,20090225,20100809,530,DAY,174843919,1,HIV infection
17574109,175741096,6,F,20170101,20230515,20200323,20230518,EXP,,US-GILEAD-2020-0456091,GILEAD,,,,A,M,Y,90.703,KG,20230518,,LW,US,US,EFAVIRENZ;SUSTIVA,Anhedonia;Anxiety;Depression;Economic problem;Emotional distress;End stage renal disease;Pain;Renal failure,175741096,HO,,,175741096,1,2006,20180109,26,DAY,175741096,1,HIV infection
17574921,175749214,4,F,20180101,20230426,20200324,20230503,PER,,US-GILEAD-2020-0455870,GILEAD,,57,YR,A,M,Y,,,20230503,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Drug ineffective;Economic problem;Emotional distress;Foot fracture;Osteopenia;Osteoporosis;Pain,175749214,OT,,,175749214,1,2006,2017,,,175749214,1,HIV infection
17575000,175750003,3,F,20171201,20230507,20200324,20230511,EXP,,US-GILEAD-2020-0455867,GILEAD,,69,YR,E,M,Y,70.295,KG,20230511,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Economic problem;Emotional distress;Hepatic cirrhosis;Osteoporosis;Pain;Spinal fracture,175750003,OT,,,175750003,1,2006,201608,279,DAY,175750003,1,HIV infection
17575701,175757013,3,F,20090101,20230406,20200324,20230411,EXP,,US-GILEAD-2020-0456183,GILEAD,,,,A,M,Y,88.4,KG,20230411,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Economic problem;Emotional distress;Pain,175757013,OT,,,175757013,1,2013,2015,,,175757013,1,HIV infection
17576959,175769593,3,F,20090604,20230417,20200324,20230420,EXP,,US-GILEAD-2020-0455949,GILEAD,,62,YR,A,M,Y,74.83,KG,20230420,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Economic problem;Emotional distress;Fall;Hip fracture;Osteoporosis;Pain,175769593,HO,,,175769593,1,2001,20120423,,,175769593,1,HIV infection
17577037,175770373,3,F,20100401,20230405,20200324,20230411,EXP,,US-GILEAD-2020-0456126,GILEAD,,44,YR,A,M,Y,77,KG,20230411,,LW,US,US,SUSTIVA,Anhedonia;Ankle fracture;Anxiety;Blood creatinine increased;Bone density decreased;Economic problem;Emotional distress;Osteonecrosis;Osteoporosis;Pain;Renal failure;Renal impairment;Spinal osteoarthritis;Tibia fracture,175770373,OT,,,175770373,1,2004,201412,,,175770373,1,HIV infection
17579467,175794675,5,F,20150101,20230407,20200325,20230413,EXP,,US-GILEAD-2020-0456157,GILEAD,,,,A,M,Y,68.027,KG,20230413,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Arthritis;Bone demineralisation;Decreased activity;Depression;Diarrhoea;Economic problem;Emotional distress;Fatigue;Headache;Hip arthroplasty;Left ventricular failure;Osteonecrosis;Osteoporosis;Pain,175794675,OT,,,175794675,1,20100802,20170729,2553,DAY,175794675,1,HIV infection
17579753,175797533,3,F,20060101,20230512,20200325,20230517,EXP,,US-GILEAD-2020-0456111,GILEAD,,,,A,F,Y,140.59,KG,20230517,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Depression;Dyspnoea;Economic problem;Emotional distress;Gait disturbance;Pain,175797533,OT,,,175797533,2,2004,2017,,,175797533,1,HIV infection
17579788,175797883,3,F,20140201,20230505,20200325,20230509,EXP,,US-GILEAD-2020-0455851,GILEAD,,71,YR,E,M,Y,69,KG,20230509,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Economic problem;Emotional distress;Hyperparathyroidism;Hypokalaemia;Osteopenia;Pain;Proteinuria;Renal impairment,175797883,OT,,,175797883,1,2006,2013,,,175797883,1,HIV infection
17580644,175806443,3,F,20110101,20230424,20200325,20230426,EXP,,US-GILEAD-2020-0456171,GILEAD,,,,A,M,Y,81.633,KG,20230426,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Depression;Economic problem;Emotional distress;End stage renal disease;Pain;Renal failure;Skin lesion,175806443,OT,,,175806443,1,201208,201209,1,MON,175806443,1,HIV infection
17718876,177188766,6,F,20180101,20230609,20200428,20230613,EXP,,US-GILEAD-2020-0461588,GILEAD,,,,A,F,Y,35.374,KG,20230613,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Bone disorder;Bone loss;Bone pain;Emotional distress;Foot fracture;Hand fracture;Liver disorder;Loss of personal independence in daily activities;Multiple fractures;Osteonecrosis;Osteoporosis;Pain;Renal disorder;Renal injury;Skeletal injury;Spinal fracture,177188766,HO,,,177188766,1,201001,201908,,,177188766,1,HIV infection
17721939,177219394,4,F,20050101,20211108,20200429,20230406,EXP,,US-GILEAD-2020-0462221,GILEAD,,,,A,M,Y,81.63,KG,20230406,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Bone loss;Bone pain;Emotional distress;Exercise tolerance decreased;Gait disturbance;Multiple fractures;Muscular weakness;Osteonecrosis;Osteoporosis;Pain;Renal impairment;Renal injury;Skeletal injury,177219394,OT,,,177219394,1,2001,2002,,,177219394,1,HIV infection
17727228,177272287,7,F,20150102,20230519,20200430,20230524,EXP,,US-GILEAD-2020-0460881,GILEAD,,65,YR,E,F,Y,61.224,KG,20230524,,LW,US,US,SUSTIVA,Acute kidney injury;Azotaemia;Blood creatinine increased;Chronic kidney disease;Economic problem;Emotional distress;Fanconi syndrome acquired;Insomnia;Malaise;Pain;Pollakiuria;Renal disorder;Renal failure;Renal impairment;Renal tubular disorder,177272287,OT,,,177272287,1,20150904,20151021,47,DAY,177272287,1,HIV infection
17736679,177366795,5,F,20170101,20230403,20200501,20230407,PER,,US-GILEAD-2020-0463103,GILEAD,,,,A,M,Y,72.562,KG,20230407,,LW,US,US,SUSTIVA,Acute kidney injury;Anaemia;Chronic kidney disease;End stage renal disease;Hepatitis C;Hyperkalaemia;Hypertension;Renal failure,177366795,HO,,,177366795,1,2004,2016,,,177366795,1,HIV infection
17949727,1794972718,18,F,,20230426,20200626,20230509,EXP,CA-MHPD-E2B_02966351,CA-Accord-186554,ACCORD,,54,YR,A,M,Y,,,20230509,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Incorrect route of product administration;Intentional product use issue;Loss of personal independence in daily activities;Prescribed overdose,1794972718,HO,,,,,,,,,1794972718,1,Bipolar disorder
18007417,180074179,9,F,20120101,20230524,20200710,20230528,EXP,,US-GILEAD-2020-0481205,GILEAD,,,,A,F,Y,54.422,KG,20230528,,LW,US,US,SUSTIVA,Anxiety;Bone density decreased;Chronic kidney disease;Depression;Drug dependence;Dysstasia;Emotional distress;Fanconi syndrome acquired;Femur fracture;Gait disturbance;Metabolic acidosis;Osteoporosis;Pain;Pancreatitis;Renal failure,180074179,OT,,,180074179,1,20080101,20080601,5,MON,180074179,1,HIV infection
18021486,180214864,4,F,20050101,20230511,20200714,20230516,EXP,,US-GILEAD-2020-0482560,GILEAD,,59,YR,A,M,Y,,,20230516,,LW,US,US,SUSTIVA,Blood creatinine increased;Bone density decreased;Chronic kidney disease;Multiple fractures;Osteonecrosis of jaw;Osteoporosis;Pain;Renal failure;Tooth fracture;Tooth loss,180214864,OT,,,180214864,1,20080602,20091102,17,MON,180214864,1,HIV infection
18065589,180655897,7,F,,20230426,20200724,20230508,EXP,CA-MHPD-E2B_02992182,CA-Accord-191476,ACCORD,,44,YR,A,M,Y,,,20230508,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor retardation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,180655897,HO,,,180655897,13,,,365,DAY,180655897,1,Depression
18065982,180659824,4,F,20160101,20230407,20200724,20230412,EXP,,LV-ABBVIE-20K-287-3495672-00,ABBVIE,,45,YR,,F,Y,,,20230412,,MD,LV,LV,EFAVIRENZ,Blood HIV RNA increased;Drug resistance;Hyperhidrosis;Live birth;Maternal exposure during pregnancy;Therapy change,180659824,OT,,,180659824,1,2015,,,,180659824,1,HIV infection
18067088,180670883,3,F,20071001,20230411,20200724,20230413,EXP,,US-GILEAD-2020-0485091,GILEAD,,46,YR,A,M,Y,95.238,KG,20230413,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Depression;Emotional distress;Pain;Renal impairment,180670883,OT,,,180670883,1,200708,2014,,,180670883,1,HIV infection
18068131,180681313,3,F,20090101,20230501,20200724,20230504,EXP,,US-GILEAD-2020-0485178,GILEAD,,,,A,F,Y,142.86,KG,20230504,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Arthritis;Depression;Emotional distress;Gait disturbance;Loss of personal independence in daily activities;Osteoporosis;Pain,180681313,OT,,,180681313,1,2001,201605,,,180681313,1,HIV infection
18068866,180688663,3,F,20130101,20230427,20200724,20230503,PER,,US-GILEAD-2020-0485048,GILEAD,,,,A,M,Y,86.18,KG,20230503,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Emotional distress;Pain;Renal impairment,180688663,OT,,,180688663,1,2008,201506,,,180688663,1,HIV infection
18074485,180744852,2,F,20160101,20230512,20200727,20230518,EXP,,US-GILEAD-2020-0485549,GILEAD,,,,A,M,Y,86.168,KG,20230518,,LW,US,US,SUSTIVA,Acute kidney injury;Acute respiratory failure;Anaemia;Chronic kidney disease;Craniocerebral injury;Emotional distress;End stage renal disease;Metabolic acidosis;Pain;Renal failure;Status epilepticus,180744852,OT,,,180744852,1,2010,2017,,,180744852,1,HIV infection
18077791,180777912,2,F,20080201,20230429,20200727,20230504,EXP,,US-GILEAD-2020-0484975,GILEAD,,60,YR,E,F,Y,104.31,KG,20230504,,LW,US,US,SUSTIVA,Emotional distress;Osteoporosis;Pain,180777912,OT,,,180777912,1,2004,20130629,1985,DAY,180777912,1,HIV infection
18096248,180962485,5,F,20140101,20230515,20200730,20230519,PER,,US-GILEAD-2020-0487166,GILEAD,,56,YR,A,M,Y,113.39,KG,20230519,,LW,US,US,SUSTIVA,Acute kidney injury;Emotional distress;Fanconi syndrome acquired;Pain;Proteinuria;Renal impairment,180962485,HO,,,180962485,1,20070227,20170919,3857,DAY,180962485,1,HIV infection
18102678,181026783,3,F,20120101,20230602,20200803,20230606,EXP,,US-GILEAD-2020-0486585,GILEAD,,39,YR,A,M,Y,73.469,KG,20230606,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Pain;Renal failure,181026783,OT,,,181026783,1,2011,2016,520,DAY,181026783,1,HIV infection
18105559,181055595,5,F,20080101,20230421,20200804,20230425,EXP,,US-GILEAD-2020-0486479,GILEAD,,42,YR,A,M,Y,81.633,KG,20230425,,LW,US,US,SUSTIVA,Abdominal discomfort;Abnormal dreams;Anhedonia;Anxiety;Bone density decreased;Bone disorder;Bone loss;Decreased appetite;Emotional distress;Femur fracture;Hand fracture;Lower limb fracture;Multiple fractures;Osteonecrosis;Osteopenia;Osteoporosis;Pain;Renal injury;Skeletal injury;Weight decreased,181055595,HO,,,181055595,1,2004,2017,1363,DAY,181055595,1,HIV infection
18109928,181099283,3,F,20100201,20230429,20200804,20230503,PER,,US-GILEAD-2020-0486821,GILEAD,,56,YR,A,M,Y,72.562,KG,20230503,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Emotional distress;Osteopenia;Pain,,,,,181099283,1,2006,201902,,,181099283,1,HIV infection
18110465,181104653,3,F,20130508,20230405,20200804,20230411,EXP,,US-GILEAD-2020-0486802,GILEAD,,41,YR,A,M,Y,85,KG,20230411,,LW,US,US,EFAVIRENZ;SUSTIVA,Abdominal pain;Anhedonia;Ankle fracture;Anxiety;Chronic kidney disease;Dizziness;Emotional distress;Loss of consciousness;Pain;Pyrexia;Syncope,181104653,HO,,,181104653,1,2001,2007,328,DAY,181104653,1,HIV infection
18110954,181109543,3,F,20140701,20230501,20200804,20230504,EXP,,US-GILEAD-2020-0488466,GILEAD,,22,YR,A,F,Y,55.782,KG,20230504,,LW,US,US,SUSTIVA,Chronic kidney disease;Emotional distress;End stage renal disease;Pain;Renal failure,181109543,HO,,,181109543,1,201011,201212,1022,DAY,181109543,1,HIV infection
18111305,181113054,4,F,20160101,20230414,20200804,20230418,EXP,,LV-009507513-2007LVA010997,MERCK,,45,YR,,F,Y,,,20230418,,MD,LV,LV,EFAVIRENZ,Blood HIV RNA increased;Drug resistance;Hyperhidrosis;Therapy change,181113054,OT,,,181113054,1,2015,,,,181113054,1,HIV infection
18141192,181411923,3,F,20110901,20230424,20200812,20230427,EXP,,US-GILEAD-2020-0489338,GILEAD,,63,YR,A,M,Y,76.19,KG,20230427,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Depression;Emotional distress;Mobility decreased;Osteopenia;Pain,181411923,OT,,,181411923,1,2008,201109,56,DAY,181411923,1,HIV infection
18147382,181473824,4,F,20130101,20230402,20200813,20230406,EXP,,US-GILEAD-2020-0489260,GILEAD,,41,YR,A,M,Y,111.11,KG,20230406,,LW,US,US,EFAVIRENZ;EFAVIRENZ;EMTRICITABINE;TENOFOVIR;SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Bone density decreased;Chronic kidney disease;Emotional distress;Pain;Renal impairment,181473824,HO,,,181473824,1,2001,201607,,,181473824,1,HIV infection
18157901,181579013,3,F,20090101,20230414,20200817,20230418,EXP,,US-GILEAD-2020-0489192,GILEAD,,59,YR,A,M,Y,141.95,KG,20230418,,LW,US,US,SUSTIVA,Anxiety;Blood creatinine increased;Bone demineralisation;Chronic kidney disease;Depression;Emotional distress;Femur fracture;Insomnia;Osteoporosis;Pain,181579013,OT,,,181579013,1,2004,2009,,,181579013,1,HIV infection
18158157,181581573,3,F,20141126,20230419,20200817,20230424,EXP,,US-GILEAD-2020-0489417,GILEAD,,51,YR,A,M,Y,123.36,KG,20230424,,LW,US,US,SUSTIVA,Acute kidney injury;Anxiety;Blood creatinine increased;Bone density decreased;Chronic kidney disease;Emotional distress;Osteoporosis;Pain,181581573,OT,,,181581573,1,2001,2020,,,181581573,1,HIV infection
18158290,181582903,3,F,20150501,20230403,20200817,20230407,EXP,,US-GILEAD-2020-0489759,GILEAD,,49,YR,A,F,Y,68.027,KG,20230407,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Depression;Emotional distress;Pain;Renal tubular acidosis,181582903,OT,,,181582903,1,2006,2018,,,181582903,1,HIV infection
18158478,181584784,4,F,20160101,20230404,20200817,20230407,EXP,,US-GILEAD-2020-0490412,GILEAD,,,,A,M,Y,104.31,KG,20230407,,LW,US,US,EFAVIRENZ;SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Pain;Proteinuria,181584784,OT,,,181584784,1,2012,2018,2353,DAY,181584784,1,HIV infection
18160188,181601882,2,F,20051201,20230412,20200817,20230418,EXP,,US-GILEAD-2020-0489476,GILEAD,,48,YR,A,M,Y,185,KG,20230418,,LW,US,US,SUSTIVA,Anxiety;Back pain;Blood creatinine increased;Bone density decreased;Chronic kidney disease;Depression;Emotional distress;Erectile dysfunction;Fatigue;Incontinence;Pain;Pollakiuria;Post-traumatic stress disorder;Proteinuria;Restlessness,181601882,OT,,,181601882,1,2001,2017,,,181601882,1,HIV infection
18163556,181635563,3,F,20150101,20230414,20200818,20230419,PER,,US-GILEAD-2020-0490410,GILEAD,,52,YR,A,M,Y,72.562,KG,20230419,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Arthralgia;Bone demineralisation;Drug ineffective;Emotional distress;Myalgia;Pain;Pain in extremity,181635563,OT,,,181635563,1,2004,20181016,,,181635563,1,HIV infection
18164183,181641833,3,F,20140101,20230414,20200818,20230418,EXP,,US-GILEAD-2020-0490397,GILEAD,,59,YR,A,M,Y,95.238,KG,20230418,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Chronic kidney disease;Chronic kidney disease-mineral and bone disorder;Decreased activity;Emotional distress;Pain;Renal tubular acidosis,181641833,OT,,,181641833,1,2006,201408,,,181641833,1,HIV infection
18164238,181642383,3,F,20050101,20230501,20200818,20230504,EXP,,US-GILEAD-2020-0490115,GILEAD,,,,A,M,Y,61.224,KG,20230504,,LW,US,US,SUSTIVA,Anxiety;Chronic kidney disease;Depression;Emotional distress;Pain;Renal impairment,181642383,OT,,,181642383,1,2004,20111214,,,181642383,1,HIV infection
18168922,181689224,4,F,20170310,20230606,20200818,20230612,EXP,,US-GILEAD-2020-0489977,GILEAD,,38,YR,A,F,Y,63.492,KG,20230612,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Emotional distress;Nephropathy;Pain;Renal failure;Renal injury,181689224,HO,,,181689224,1,2009,201202,,,181689224,1,HIV infection
18168943,181689436,6,F,20090101,20230509,20200818,20230516,EXP,,US-GILEAD-2020-0489652,GILEAD,,,,A,M,Y,58.957,KG,20230516,,LW,US,US,SUSTIVA,Anhedonia;Ankle fracture;Anxiety;Blood creatinine increased;Bone demineralisation;Bone density decreased;Emotional distress;Hip fracture;Osteoporosis;Pain;Protein urine present;Renal impairment;Rotator cuff syndrome;Tendon rupture;Wrist fracture,181689436,OT,,,181689436,1,2006,201612,,,181689436,1,HIV infection
18171201,181712013,3,F,20060101,20230502,20200819,20230508,EXP,,US-GILEAD-2020-0489986,GILEAD,,,,A,M,Y,70.3,KG,20230508,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Pain,181712013,OT,,,181712013,1,2003,2006,,,181712013,1,HIV infection
18171264,181712645,5,F,20160101,20230331,20200819,20230405,EXP,,US-GILEAD-2020-0490139,GILEAD,,54,YR,A,M,Y,114.29,KG,20230405,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Bone loss;Depression;Emotional distress;Multiple fractures;Osteonecrosis;Osteoporosis;Pain;Renal injury;Skeletal injury;Tooth loss,181712645,OT,,,181712645,1,2004,2008,,,181712645,1,HIV infection
18172100,181721003,3,F,20180901,20230502,20200819,20230505,EXP,,US-GILEAD-2020-0490070,GILEAD,,47,YR,A,M,Y,63.492,KG,20230505,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Emotional distress;Lower limb fracture;Multiple fractures;Osteoporosis;Pain,181721003,OT,,,181721003,1,2006,201809,,,181721003,1,HIV infection
18172426,181724263,3,F,20080801,20230331,20200820,20230404,PER,,US-GILEAD-2020-0490168,GILEAD,,48,YR,A,F,Y,99.773,KG,20230404,,LW,US,US,EFAVIRENZ;SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Injury;Osteopenia;Pain,,,,,181724263,1,2001,201705,,,181724263,1,HIV infection
18179064,181790645,5,F,20080301,20230503,20200821,20230508,EXP,,US-GILEAD-2020-0490483,GILEAD,,60,YR,A,M,Y,77.1,KG,20230508,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Blood creatinine increased;Chronic kidney disease;Drug ineffective;Emotional distress;Pain,181790645,HO,,,181790645,1,2001,200508,,,181790645,1,HIV infection
18183207,181832074,4,F,20180701,20230413,20200821,20230420,EXP,,US-GILEAD-2020-0489941,GILEAD,,47,YR,A,M,Y,79.365,KG,20230420,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Bone density decreased;Emotional distress;Fracture;Pain,181832074,OT,,,181832074,1,2004,2010,,,181832074,1,HIV infection
18184143,181841433,3,F,20080101,20230501,20200823,20230505,EXP,,US-GILEAD-2020-0491100,GILEAD,,,,A,M,Y,96.145,KG,20230505,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Bone density decreased;Emotional distress;Fracture;Osteoporosis;Pain;Renal impairment,181841433,OT,,,181841433,1,2004,2018,,,181841433,1,HIV infection
18184148,181841483,3,F,20070101,20230422,20200824,20230425,EXP,,US-GILEAD-2020-0491250,GILEAD,,51,YR,A,M,Y,77.098,KG,20230425,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Bone disorder;Bone loss;Chronic kidney disease;Depression;Emotional distress;Foot fracture;Nightmare;Osteoporosis;Pain;Renal impairment;Stress fracture,181841483,OT,,,181841483,1,2006,2012,,,181841483,1,HIV infection
18196776,181967764,4,F,20060101,20230404,20200826,20230407,EXP,,US-GILEAD-2020-0491925,GILEAD,,,,A,M,Y,120.64,KG,20230407,,LW,US,US,SUSTIVA,Anxiety;Blood creatinine increased;Emotional distress;Fatigue;Feeling drunk;Headache;Migraine;Mood swings;Nephrolithiasis;Pain;Renal impairment,181967764,HO,,,181967764,1,2006,2012,,,181967764,1,HIV infection
18198021,181980213,3,F,20150101,20230421,20200826,20230425,EXP,,US-GILEAD-2020-0491862,GILEAD,,44,YR,A,M,Y,81.633,KG,20230425,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Bone density decreased;Bone loss;Dysstasia;Emotional distress;Loose tooth;Multiple fractures;Osteopenia;Osteoporosis;Pain;Stress fracture,181980213,OT,,,181980213,1,200403,201801,,,181980213,1,HIV infection
18205129,182051295,5,F,20140101,20230512,20200828,20230517,PER,,US-GILEAD-2020-0491856,GILEAD,,,,A,M,Y,87.528,KG,20230517,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Bone density decreased;Eating disorder;Emotional distress;Pain;Renal failure;Urinary incontinence,182051295,OT,,,182051295,1,2010,2012,,,182051295,1,HIV infection
18206163,182061632,2,F,20150501,20230426,20200827,20230428,EXP,,US-GILEAD-2020-0491423,GILEAD,,41,YR,A,M,Y,88.889,KG,20230428,,LW,US,US,SUSTIVA,Chronic kidney disease;Emotional distress;Mobility decreased;Pain;Renal failure,182061632,HO,,,182061632,1,2012,2015,,,182061632,1,HIV infection
18213241,182132413,3,F,20150101,20230418,20200831,20230428,EXP,,LV-TEVA-2020-LV-1820060,TEVA,,45,YR,A,F,Y,,,20230428,,CN,LV,LV,EFAVIRENZ,Blood HIV RNA increased;Drug resistance;Exposure during pregnancy;Hyperhidrosis;Therapy change,182132413,OT,,,182132413,1,2015,,,,182132413,1,HIV infection
18222336,182223362,2,F,,20230330,20200902,20230407,EXP,,CA-AstraZeneca-2020SF10318,ASTRAZENECA,,54,YR,,M,Y,,,20230407,,MD,CA,,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,182223362,OT,,,,,,,,,182223362,1,Bipolar disorder
18242103,182421033,3,F,20170501,20230413,20200908,20230419,EXP,,US-GILEAD-2020-0494027,GILEAD,,51,YR,A,M,Y,81.633,KG,20230419,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Blood creatinine increased;Chronic kidney disease;Emotional distress;Pain,182421033,OT,,,182421033,1,2009,2012,,,182421033,1,HIV infection
18256570,182565703,3,F,20140101,20230418,20200911,20230421,EXP,,US-GILEAD-2020-0494621,GILEAD,,,,A,M,Y,68.027,KG,20230421,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Depression;Emotional distress;Foot fracture;Fractured coccyx;Osteoporosis;Pain;Rib fracture;Spinal compression fracture,182565703,OT,,,182565703,1,2004,201210,,,182565703,1,HIV infection
18257450,182574503,3,F,20130101,20230428,20200911,20230504,EXP,,US-GILEAD-2020-0494599,GILEAD,,,,A,F,Y,147.39,KG,20230504,,LW,US,US,SUSTIVA,Emotional distress;End stage renal disease;Pain,182574503,OT,,,182574503,1,2006,2018,,,182574503,1,HIV infection
18269468,182694683,3,F,20071211,20230510,20200915,20230515,EXP,,US-GILEAD-2020-0494476,GILEAD,,47,YR,A,M,Y,92.517,KG,20230515,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;End stage renal disease;Pain,182694683,OT,,,182694683,1,2001,2006,,,182694683,1,HIV infection
18306235,183062352,2,F,,20230409,20200924,20230419,EXP,,CA-TEVA-2020-CA-1830303,TEVA,,54,YR,A,M,Y,,,20230419,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Psychiatric decompensation,183062352,HO,,,,,,,,,183062352,1,HIV infection
18385419,183854192,2,F,,20230516,20201015,20230518,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-076820,BRISTOL MYERS SQUIBB,,55,YR,A,M,Y,,,20230518,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Emotional distress;Pain,,,,,183854192,1,20040315,2008,1388,DAY,183854192,1,HIV infection
18387262,183872625,5,F,20160401,20230613,20201015,20230616,EXP,,US-GILEAD-2020-0498473,GILEAD,,47,YR,A,M,Y,,,20230616,,LW,US,US,SUSTIVA,Bone density decreased;Osteopenia;Osteoporosis;Spinal disorder;Spinal stenosis;Tooth loss,183872625,OT,,,183872625,1,2006,2016,,,183872625,1,HIV infection
18531452,185314524,4,F,,20230510,20201122,20230519,EXP,,CA-JNJFOC-20201124162,JOHNSON AND JOHNSON,,44,YR,A,M,Y,,,20230519,,HP,CA,CA,SUSTIVA,Abdominal pain;Anxiety;Constipation;Depression;Depression suicidal;Depressive symptom;Drug interaction;Gastric infection;Muscle rigidity;Off label use;Pain;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor retardation;Psychomotor skills impaired;Psychotic disorder;Rebound effect;Retching;Salivary hypersecretion;Sedation;Suicidal ideation;Tearfulness,185314524,OT,,,185314524,12,,,161,DAY,185314524,1,Major depression
18564882,185648822,2,F,20110101,20230605,20201201,20230608,EXP,,US-GILEAD-2020-0503846,GILEAD,,,,A,M,Y,54.422,KG,20230608,,LW,US,US,SUSTIVA,Anaemia;Anhedonia;Anxiety;Blood creatinine increased;Chronic kidney disease;Chronic kidney disease-mineral and bone disorder;Emotional distress;Hyperkalaemia;Hypertension;Pain;Renal tubular acidosis,185648822,OT,,,185648822,1,2004,2017,,,185648822,1,HIV infection
18641058,186410583,3,F,20130901,20230403,20201221,20230407,EXP,,US-GILEAD-2020-0509278,GILEAD,,49,YR,A,F,Y,147.39,KG,20230406,,LW,US,US,SUSTIVA,Anaemia;Anhedonia;Anxiety;Cardiac failure congestive;Depression;Emotional distress;End stage renal disease;Fatigue;Lethargy;Negative thoughts;Pain;Renal failure;Renal impairment,186410583,OT,,,186410583,1,2001,201812,,,186410583,1,HIV infection
18646310,186463104,4,F,20110101,20230412,20201222,20230418,EXP,,US-GILEAD-2020-0509313,GILEAD,,,,A,M,Y,77.098,KG,20230418,,LW,US,US,EFAVIRENZ,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;End stage renal disease;Gait disturbance;Hypertension;Pain;Renal failure;Renal impairment;Sleep disorder,186463104,OT,,,186463104,1,2004,2015,,,186463104,1,HIV infection
18661112,186611123,3,F,20170101,20230426,20201224,20230501,PER,,US-GILEAD-2020-0509320,GILEAD,,,,A,F,Y,109.75,KG,20230501,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Emotional distress;Pain;Renal failure,186611123,HO,,,186611123,1,2001,2006,,,186611123,1,HIV infection
18739723,187397233,3,F,20050401,20230418,20210114,20230425,EXP,,JP-VIIV HEALTHCARE LIMITED-JP2021JPN003775,VIIV,Tomohiro Hosoda. The current situation of 3TC+DTG in our hospital. E2 HIV Expert Forum in Tokyo. 2023,,,,,Y,,,20230425,,MD,JP,JP,EFAVIRENZ,Blood lactate dehydrogenase increased;Diabetes mellitus;Dyslipidaemia;Glomerular filtration rate decreased;Proteinuria;Renal impairment,187397233,OT,,,187397233,1,201302,,,,187397233,1,HIV infection
18739841,187398413,3,F,20050401,20230418,20210114,20230425,EXP,,JP-GLAXOSMITHKLINE-JP2021JPN003775,GLAXOSMITHKLINE,Tomohiro Hosoda. The current situation of 3TC+DTG in our hospital. E2 HIV Expert Forum in Tokyo. 2023,,,,,Y,,,20230425,,MD,JP,JP,EFAVIRENZ,Blood lactate dehydrogenase increased;Diabetes mellitus;Dyslipidaemia;Glomerular filtration rate decreased;Proteinuria;Renal impairment,187398413,OT,,,187398413,1,201302,,,,187398413,1,HIV infection
18786658,187866583,3,F,20120101,20230403,20210126,20230407,EXP,,US-GILEAD-2021-0513366,GILEAD,,,,A,M,Y,54.431,KG,20230406,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Blood urine present;Chronic kidney disease;Discomfort;Emotional distress;Grip strength decreased;Joint contracture;Nephrolithiasis;Osteoporosis;Pain;Upper limb fracture,187866583,OT,,,187866583,1,200609,201404,,,187866583,1,HIV infection
18796595,187965953,3,F,20050101,20230329,20210128,20230403,EXP,,US-GILEAD-2021-0513358,GILEAD,,64,YR,A,M,Y,65.3,KG,20230403,,LW,US,US,EFAVIRENZ,Anhedonia;Anxiety;Clavicle fracture;Depression;Emotional distress;Osteonecrosis;Osteopenia;Osteoporosis;Pain;Shoulder fracture;Wrist fracture,187965953,OT,,,187965953,1,2005,2015,,,187965953,1,HIV infection
18796763,187967633,3,F,20070101,20230612,20210128,20230615,EXP,,US-GILEAD-2021-0513451,GILEAD,,,,A,M,Y,70.295,KG,20230615,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Chronic kidney disease;Emotional distress;Osteoporosis;Pain;Renal injury;Vitamin D deficiency,187967633,OT,,,187967633,1,2005,2010,,,187967633,1,HIV infection
18796772,187967723,3,F,20101001,20230422,20210128,20230424,PER,,US-GILEAD-2021-0513381,GILEAD,,43,YR,A,M,Y,79.365,KG,20230424,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Depression;Emotional distress;Osteopenia;Pain;Wrist fracture,,,,,187967723,1,2011,2019,,,187967723,1,HIV infection
18799271,187992714,4,F,20100101,20230509,20210128,20230512,EXP,,US-GILEAD-2021-0513354,GILEAD,,,,A,M,Y,119.73,KG,20230512,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Bone demineralisation;Chronic kidney disease;Depression;Emotional distress;Foot fracture;Jaw fracture;Nephropathy;Osteonecrosis;Osteopenia;Osteoporosis;Pain,187992714,OT,,,187992714,1,2005,2012,,,187992714,1,HIV infection
18801757,188017573,3,F,20090101,20230404,20210128,20230408,EXP,,US-GILEAD-2021-0513415,GILEAD,,,,A,F,Y,58.957,KG,20230408,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Hypertension;Lower limb fracture;Nephrolithiasis;Osteoporosis;Pain;Renal tubular injury,188017573,HO,,,188017573,1,2006,2004,,,188017573,1,HIV infection
18806899,188068994,4,F,20070101,20230403,20210129,20230408,EXP,,US-GILEAD-2021-0513418,GILEAD,,,,A,M,Y,77.098,KG,20230408,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Emotional distress;Lower limb fracture;Osteopenia;Osteoporosis;Pain;Tibia fracture,188068994,OT,,,188068994,1,2003,2004,,,188068994,1,HIV infection
18869891,188698913,3,F,20150101,20230414,20210209,20230419,EXP,,US-GILEAD-2021-0515572,GILEAD,,,,A,F,Y,73.93,KG,20230419,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Pain,188698913,OT,,,188698913,1,2011,2011,,,188698913,1,HIV infection
18871837,188718373,3,F,20140301,20230410,20210210,20230414,EXP,,US-GILEAD-2021-0515563,GILEAD,,47,YR,A,M,Y,79.819,KG,20230414,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Depression;Emotional distress;Exostosis;Foot fracture;Osteoarthritis;Osteoporosis;Pain;Proteinuria;Renal failure;Renal injury,188718373,OT,,,188718373,1,2004,2006,,,188718373,1,HIV infection
18871840,188718403,3,F,20080101,20230403,20210210,20230407,EXP,,US-GILEAD-2021-0515565,GILEAD,,,,A,F,Y,45.359,KG,20230407,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Hypertension;Pain,188718403,OT,,,188718403,1,2008,201402,,,188718403,1,HIV infection
18874084,188740844,4,F,20090101,20230416,20210210,20230419,PER,,US-GILEAD-2021-0515558,GILEAD,,,,A,F,Y,66.667,KG,20230419,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Emotional distress;Osteopenia;Osteoporosis;Pain;Renal impairment,188740844,OT,,,188740844,1,2004,2017,,,188740844,1,HIV infection
18881838,188818383,3,F,20120701,20230428,20210212,20230504,EXP,,US-GILEAD-2021-0515536,GILEAD,,53,YR,A,M,Y,175,KG,20230504,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Emotional distress;Fracture pain;Hand fracture;Osteoarthritis;Osteoporosis;Pain,188818383,OT,,,188818383,2,201106,2017,,,188818383,1,HIV infection
18888983,188889833,3,F,20120101,20230508,20210213,20230512,EXP,,US-GILEAD-2021-0515568,GILEAD,,,,A,F,Y,74.83,KG,20230512,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Dysstasia;Emotional distress;Fanconi syndrome acquired;Femur fracture;Foot fracture;Gait disturbance;Hip fracture;Multiple fractures;Osteomalacia;Pain,188889833,OT,,,188889833,1,2006,201408,,,188889833,1,HIV infection
18893076,188930767,7,F,,20230605,20210215,20230608,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013005,BRISTOL MYERS SQUIBB,,54,YR,A,M,Y,,,20230608,,HP,CA,CA,SUSTIVA,Depression;Drug interaction;Hospitalisation;Intentional product use issue;Loss of personal independence in daily activities;Prescribed overdose,188930767,DE,,,,,,,,,188930767,1,HIV infection
18928015,189280155,5,F,20150101,20230424,20210223,20230427,PER,,US-GILEAD-2021-0517985,GILEAD,,,,A,F,Y,83.92,KG,20230427,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Cough;Drug resistance;Emotional distress;Osteopenia;Pain;Rib fracture;Wrist fracture,189280155,OT,,,189280155,1,2006,2010,,,189280155,1,HIV infection
18934893,189348933,3,F,20110401,20230407,20210224,20230412,EXP,,US-GILEAD-2021-0517983,GILEAD,,53,YR,A,F,Y,74.83,KG,20230412,,LW,US,US,SUSTIVA,Anhedonia;Ankle fracture;Anxiety;Bacterial infection;Depression;Diarrhoea;Emotional distress;Fungal infection;Intervertebral disc degeneration;Neck pain;Osteoarthritis;Osteopenia;Pain;Upper limb fracture;Wrist fracture,189348933,OT,,,189348933,1,2008,201811,,,189348933,1,HIV infection
18986747,189867473,3,F,20150301,20230403,20210309,20230408,EXP,,US-GILEAD-2021-0519942,GILEAD,,55,YR,A,F,Y,86.168,KG,20230408,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Depression;Emotional distress;Fatigue;Fibula fracture;Hip fracture;Multiple fractures;Osteoporosis;Pain;Spinal compression fracture,189867473,OT,,,189867473,1,2010,201902,,,189867473,1,HIV infection
19074794,190747943,3,F,20110201,20230408,20210330,20230412,EXP,,US-GILEAD-2021-0523126,GILEAD,,45,YR,A,M,Y,113.38,KG,20230412,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Fatigue;Hypokinesia;Pain;Pollakiuria,190747943,OT,,,190747943,1,20090609,20101114,523,DAY,190747943,1,HIV infection
19075820,190758203,3,F,20151201,20230426,20210330,20230501,PER,,US-GILEAD-2021-0523103,GILEAD,,55,YR,A,M,Y,100.68,KG,20230501,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Dysstasia;Emotional distress;Gait disturbance;Pain;Renal failure,190758203,HO,,,190758203,1,2009,2006,,,190758203,1,HIV infection
19075869,190758693,3,F,20070801,20230407,20210330,20230412,EXP,,US-GILEAD-2021-0523102,GILEAD,,57,YR,E,F,Y,68.04,KG,20230412,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Back pain;Emotional distress;Gait disturbance;Joint range of motion decreased;Joint swelling;Multiple fractures;Osteopenia;Osteoporosis;Pain;Skeletal injury,190758693,HO,,,190758693,1,2001,201201,269,DAY,190758693,1,HIV infection
19075896,190758963,3,F,20161001,20230404,20210330,20230411,EXP,,US-GILEAD-2021-0523094,GILEAD,,52,YR,A,F,Y,83.447,KG,20230411,,LW,US,US,EFAVIRENZ;SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Chronic kidney disease;Chronic kidney disease-mineral and bone disorder;Dyspnoea;Emotional distress;End stage renal disease;Gout;Pain;Quality of life decreased;Renal failure;Renal injury,190758963,HO,,,190758963,1,2015,201909,,,190758963,1,HIV infection
19132855,191328554,4,F,20110101,20230508,20210413,20230512,PER,,US-GILEAD-2021-0524831,GILEAD,,,,E,F,Y,90.703,KG,20230512,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Drug ineffective;Emotional distress;Fatigue;Hypertension;Nephropathy;Pain;Renal failure;Renal impairment,191328554,OT,,,191328554,1,2001,2018,,,191328554,1,HIV infection
19132976,191329763,3,F,20090101,20230427,20210413,20230502,EXP,,US-GILEAD-2021-0524855,GILEAD,,52,YR,A,M,Y,80.726,KG,20230502,,LW,US,US,SUSTIVA,Amnesia;Anhedonia;Anxiety;Asthenia;Brain fog;Chronic kidney disease;Depression;Emotional distress;Exercise tolerance decreased;Fatigue;Flatulence;Insomnia;Memory impairment;Nephropathy;Pain;Pollakiuria;Renal impairment;Suicide attempt;Urinary retention,191329763,OT,,,191329763,1,2004,2006,22344,HR,191329763,1,HIV infection
19182684,1918268413,13,F,20221223,20230327,20210426,20230404,EXP,,JP-ROCHE-2818199,ROCHE,"Watanabe H, Okamura K, Urushihara M, Sugasaki M. P1-047, Hemostasis monitoring in hemophilia A during emicizumab administration.. The Japanese Journal of Pediatric Hematology/Oncology. 2022;59(4):298-.",43,YR,,M,Y,38,KG,20230404,,MD,JP,JP,EFAVIRENZ,Activated partial thromboplastin time prolonged;Haemarthrosis;Haemoglobin decreased;Haemorrhage;Infection;Muscle haemorrhage,1918268413,HO,,,1918268413,1,20201007,,,,1918268413,1,Haemophilia A with anti factor VIII
19192355,191923554,4,F,,20230417,20210429,20230430,EXP,,CA-AUROBINDO-AUR-APL-2021-016522,AUROBINDO,,54,YR,,M,Y,,,20230429,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,191923554,OT,,,,,,,,,191923554,1,HIV infection
19214814,192148143,3,F,20160101,20230512,20210504,20230516,PER,,US-GILEAD-2021-0527867,GILEAD,,,,A,M,Y,63,KG,20230516,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Depression;Emotional distress;Osteopenia;Pain,,,,,192148143,1,2004,200903,,,192148143,1,HIV infection
19215171,192151715,5,F,20190614,20230420,20210504,20230425,EXP,,US-GILEAD-2021-0527872,GILEAD,,63,YR,A,M,Y,113.38,KG,20230425,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Dyspareunia;Emotional distress;Gait disturbance;Insomnia;Multiple fractures;Osteopenia;Osteoporosis;Pain;Pathological fracture;Physical disability;Renal failure;Spinal fracture,192151715,OT,,,192151715,1,2004,202009,4602,DAY,192151715,1,HIV infection
19221587,192215873,3,F,20080901,20230511,20210505,20230515,EXP,,US-GILEAD-2021-0527899,GILEAD,,70,YR,E,M,Y,72.562,KG,20230515,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Chronic kidney disease;Depression;Emotional distress;Fall;Foot fracture;Gait disturbance;Hip fracture;Mobility decreased;Nephrolithiasis;Osteopenia;Osteoporosis;Pain,192215873,OT,,,192215873,1,200304,201108,,,192215873,1,HIV infection
19430373,194303735,5,F,20100924,20230610,20210617,20230614,EXP,,US-GILEAD-2021-0536679,GILEAD,,47,YR,A,M,Y,,,20230614,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Death;Emotional distress;Pain;Renal failure,194303735,DE,,,194303735,1,2010,20101024,,,194303735,1,HIV infection
19435753,194357533,3,F,20160501,20230420,20210618,20230424,EXP,,US-GILEAD-2021-0536647,GILEAD,,62,YR,E,M,Y,81.646,KG,20230424,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Decreased activity;Emotional distress;Osteoarthritis;Osteopenia;Osteoporosis;Pain,194357533,OT,,,194357533,1,200503,200505,,,194357533,1,HIV infection
19465462,194654623,3,F,20070101,20230518,20210624,20230524,EXP,,US-GILEAD-2021-0537436,GILEAD,,,,A,M,Y,83.9,KG,20230524,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Arthralgia;Atrial fibrillation;Blood creatinine increased;Blood lactic acid increased;Chronic kidney disease;Depression;Dizziness;Dyspnoea;Emotional distress;Hypertension;Insomnia;Muscle fatigue;Muscle spasms;Pain;Palpitations;Pollakiuria;Renal injury;Swelling,194654623,OT,,,194654623,1,2007,201801,,,194654623,1,HIV infection
19465586,194655864,4,F,20111229,20230626,20210624,20230629,PER,,US-GILEAD-2021-0537451,GILEAD,,51,YR,A,M,Y,64.41,KG,20230629,,LW,US,US,EFAVIRENZ;SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Emotional distress;Osteopenia;Pain;Spinal compression fracture,194655864,OT,,,194655864,1,2006,201108,,,194655864,1,HIV infection
19469274,194692743,3,F,20130101,20230627,20210628,20230630,EXP,,US-GILEAD-2021-0537598,GILEAD,,53,YR,A,M,Y,78.005,KG,20230630,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Asthenia;Chronic kidney disease;Emotional distress;Nephropathy;Osteoporosis;Pain;Proteinuria,194692743,OT,,,194692743,1,2007,201810,,,194692743,1,HIV infection
19608298,196082983,3,F,,20230626,20210726,20230627,EXP,,CA-BAUSCH-BL-2021-025922,BAUSCH AND LOMB,,54,YR,,M,Y,,,20230627,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,196082983,OT,,,,,,,,,196082983,1,Bipolar disorder
19634933,196349333,3,F,20110101,20230430,20210730,20230504,PER,,US-GILEAD-2021-0541785,GILEAD,,,,A,M,Y,,,20230504,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Emotional distress;Hypertension;Pain;Pollakiuria;Renal impairment,196349333,OT,,,196349333,1,2006,20180304,2330,DAY,196349333,1,HIV infection
19656612,196566123,3,F,20040101,20230613,20210804,20230615,EXP,,US-GILEAD-2021-0542302,GILEAD,,40,YR,A,M,Y,81.633,KG,20230615,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Back pain;Chronic kidney disease;Depression;Emotional distress;Fractured sacrum;Mood swings;Osteoporosis;Pain;Pollakiuria;Psychiatric symptom;Renal failure;Renal impairment,196566123,OT,,,196566123,1,2001,2004,,,196566123,1,HIV infection
19660215,196602153,3,F,20180101,20230505,20210805,20230511,EXP,,US-GILEAD-2021-0542443,GILEAD,,,,A,M,Y,124.72,KG,20230511,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Chronic kidney disease;Emotional distress;Pain,196602153,OT,,,196602153,1,20130520,201306,129,DAY,196602153,1,HIV infection
19660525,196605253,3,F,20130101,20230611,20210805,20230614,EXP,,US-GILEAD-2021-0542310,GILEAD,,71,YR,E,M,Y,,,20230614,,LW,US,US,SUSTIVA,Acute kidney injury;Anaemia;Anhedonia;Anxiety;Blood creatinine increased;Chronic kidney disease;Emotional distress;Fanconi syndrome acquired;Gastrointestinal haemorrhage;Hyperkalaemia;Loss of personal independence in daily activities;Pain;Renal impairment;Renal tubular disorder,196605253,HO,,,196605253,1,2005,20150821,,,196605253,1,HIV infection
19664910,196649103,3,F,20180101,20230512,20210805,20230517,EXP,,US-GILEAD-2021-0542366,GILEAD,,,,A,M,Y,86,KG,20230517,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Chronic kidney disease;Emotional distress;Osteopenia;Pain,196649103,OT,,,196649103,1,2008,2015,,,196649103,1,HIV infection
19812616,198126163,3,F,20170101,20230612,20210910,20230614,EXP,,US-GILEAD-2021-0547373,GILEAD,,,,A,M,Y,76.19,KG,20230614,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Bone density decreased;Chronic kidney disease;Depression;Emotional distress;Femur fracture;Hypertension;Pain;Renal impairment;Renal injury,198126163,OT,,,198126163,1,2005,202002,,,198126163,1,HIV infection
19816999,198169993,3,F,20161219,20230612,20210910,20230615,EXP,,US-GILEAD-2021-0547354,GILEAD,,58,YR,A,F,Y,57.15,KG,20230615,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Asthenia;Bone demineralisation;Chronic kidney disease;Emotional distress;Fracture;Hip fracture;Osteopenia;Osteoporosis;Pain,198169993,OT,,,198169993,1,2006,2016,,,198169993,1,HIV infection
20115964,201159644,4,F,20080101,20230610,20211126,20230614,EXP,,US-GILEAD-2021-0557151,GILEAD,,,,A,M,Y,79.37,KG,20230614,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Back pain;Bone demineralisation;Emotional distress;Mobility decreased;Osteoarthritis;Osteopenia;Osteoporosis;Pain,201159644,OT,,,201159644,1,2008,2007,,,201159644,1,HIV infection
20120093,201200933,3,F,20060801,20230418,20211126,20230421,EXP,,US-GILEAD-2021-0557450,GILEAD,,45,YR,A,M,Y,79.365,KG,20230421,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Emotional distress;Gait disturbance;Hyperlipidaemia;Loss of personal independence in daily activities;Micturition disorder;Mobility decreased;Osteopenia;Osteoporosis;Pain;Proteinuria;Rash,201200933,OT,,,201200933,1,200310,200401,,,201200933,1,HIV infection
20151279,201512793,3,F,20150513,20230609,20211206,20230612,PER,,US-GILEAD-2021-0557334,GILEAD,,52,YR,A,M,Y,57,KG,20230612,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Asthenia;Bone demineralisation;Emotional distress;Muscular weakness;Osteopenia;Pain;Weight decreased;Wrist fracture,,,,,201512793,1,2011,201712,,,201512793,1,HIV infection
20299652,202996523,3,F,20150501,20230606,20220105,20230608,PER,,US-GILEAD-2022-0563898,GILEAD,,62,YR,A,M,Y,82.086,KG,20230608,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Bone pain;Emotional distress;Mobility decreased;Osteopenia;Pain;Renal impairment;Upper limb fracture,202996523,OT,,,202996523,1,2006,201602,,,202996523,1,HIV infection
20303092,203030923,3,F,20080101,20230607,20220106,20230614,EXP,,US-GILEAD-2022-0563736,GILEAD,,53,YR,A,F,Y,81.646,KG,20230614,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Chronic kidney disease;Depression;Emotional distress;Feeding disorder;Foot fracture;Gait disturbance;General physical health deterioration;Lower limb fracture;Osteopenia;Osteoporosis;Pain;Renal impairment;Wrist fracture,203030923,OT,,,203030923,1,2008,201505,,,203030923,1,HIV infection
20304292,203042923,3,F,20081101,20230605,20220106,20230607,PER,,US-GILEAD-2022-0563855,GILEAD,,42,YR,A,M,Y,122.45,KG,20230607,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone demineralisation;Depression;Emotional distress;Hand fracture;Osteopenia;Pain;Tooth loss;Wrist fracture,,,,,203042923,1,2012,201606,,,203042923,1,HIV infection
20355563,203555633,3,F,20170601,20230609,20220120,20230616,EXP,,US-GILEAD-2022-0565913,GILEAD,,66,YR,E,M,Y,71.21,KG,20230616,,LW,US,US,EFAVIRENZ;SUSTIVA,Anhedonia;Anxiety;Asthenia;Bone demineralisation;Emotional distress;Osteoporosis;Pain,203555633,OT,,,203555633,1,2006,2018,,,203555633,1,HIV infection
20367048,203670483,3,F,20160101,20230530,20220123,20230531,PER,,US-GILEAD-2022-0566484,GILEAD,,,,A,M,Y,71.202,KG,20230531,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Bone density decreased;Emotional distress;General physical health deterioration;Pain,,,,,203670483,1,2010,201605,,,203670483,1,HIV infection
20367543,203675433,3,F,20130101,20230622,20220124,20230627,EXP,,US-GILEAD-2022-0565789,GILEAD,,,,A,F,Y,93.424,KG,20230627,,LW,US,US,SUSTIVA,Anaemia;Anhedonia;Anxiety;Asthenia;Blood creatinine increased;Chronic kidney disease;Emotional distress;End stage renal disease;Fatigue;Hyperparathyroidism secondary;Pain;Renal disorder,203675433,OT,,,203675433,1,2005,2017,,,203675433,1,HIV infection
20379763,203797634,4,F,20010101,20230609,20220126,20230613,PER,,US-GILEAD-2022-0566491,GILEAD,,,,A,M,Y,49.895,KG,20230613,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Asthenia;Bone demineralisation;Bone density decreased;Emotional distress;Eye inflammation;Hypersensitivity;Lower limb fracture;Mobility decreased;Musculoskeletal disorder;Osteoporosis;Pain;Rib fracture,203797634,OT,,,203797634,1,2001,2003,,,203797634,1,HIV infection
20448026,204480263,3,F,20120701,20230517,20220209,20230519,EXP,,US-GILEAD-2022-0569042,GILEAD,,56,YR,A,M,Y,81.647,KG,20230519,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Asthenia;Emotional distress;Fatigue;Osteoporosis;Pain,204480263,OT,,,204480263,1,2002,201302,,,204480263,1,HIV infection
20479484,204794843,3,F,20090101,20230623,20220216,20230626,PER,,US-GILEAD-2022-0569130,GILEAD,,46,YR,A,M,Y,78.458,KG,20230626,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Back pain;Bone demineralisation;Dysstasia;Emotional distress;Fractured coccyx;Impaired driving ability;Orthostatic hypotension;Osteopenia;Pain;Tinnitus;Tooth loss;Upper limb fracture,,,,,204794843,1,2006,201802,,,204794843,1,HIV infection
20481671,204816713,3,F,20170101,20230615,20220216,20230619,PER,,US-GILEAD-2022-0569116,GILEAD,,52,YR,A,M,Y,185,KG,20230619,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Balance disorder;Bone density decreased;Emotional distress;Gait disturbance;Osteopenia;Pain;Tooth loss,,,,,204816713,1,2011,2017,,,204816713,1,HIV infection
20484656,204846563,3,F,20170101,20230626,20220217,20230628,PER,,US-GILEAD-2022-0569088,GILEAD,,,,A,M,Y,77.098,KG,20230628,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Depression;Emotional distress;General physical health deterioration;Osteopenia;Pain,,,,,204846563,1,2005,2016,,,204846563,1,HIV infection
20574147,205741475,5,F,20110501,20230518,20220309,20230524,PER,,US-GILEAD-2022-0572977,GILEAD,,48,YR,A,M,Y,,,20230524,,LW,US,US,SUSTIVA,Acute kidney injury;Anhedonia;Anxiety;Blood creatinine increased;Bone demineralisation;Chronic kidney disease;Drug ineffective;Emotional distress;Fall;Foot fracture;Loss of personal independence in daily activities;Osteoporosis;Pain;Renal impairment,205741475,OT,,,205741475,1,2010,202011,,,205741475,1,HIV infection
20601438,206014383,3,F,,20230323,20220316,20230406,EXP,,ZA-CIPLA (EU) LIMITED-2022ZA01722,CIPLA,"Siddiqui N, Mansfield BS, Olmesdahl NP, Swart P, Nel J. A Severe Case of Molluscum Contagiosum Immune Reconstitution Inflammatory Syndrome in a Patient with Human Immunodeficiency Virus. European Journal of Case Reports in Internal Medicine. 2022;9 (1)",,,,,Y,,,20230406,,MD,ZA,ZA,EFAVIRENZ,Acute kidney injury;Condition aggravated;Immune reconstitution inflammatory syndrome;Molluscum contagiosum;Normocytic anaemia;Paradoxical drug reaction,206014383,DE,,,,,,,,,206014383,1,Antiretroviral therapy
20687035,206870353,3,F,20150101,20230407,20220407,20230414,EXP,,US-JNJFOC-20200934182,JOHNSON AND JOHNSON,,,,A,M,Y,68.027,KG,20230414,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Arthritis;Bone demineralisation;Decreased activity;Depression;Diarrhoea;Economic problem;Emotional distress;Fatigue;Headache;Hip arthroplasty;Left ventricular failure;Osteonecrosis;Osteoporosis;Pain,206870353,OT,,,206870353,2,20100802,20170729,2553,DAY,206870353,1,HIV infection
20728978,207289783,3,F,20131201,20230504,20220420,20230510,EXP,,US-GILEAD-2022-0578499,GILEAD,,49,YR,A,M,Y,74.84,KG,20230510,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Blood creatinine increased;Chronic kidney disease;Emotional distress;Pain,207289783,OT,,,207289783,1,2012,201312,,,207289783,1,HIV infection
20729014,207290144,4,F,20120901,20230518,20220420,20230523,EXP,,US-GILEAD-2022-0578486,GILEAD,,55,YR,A,M,Y,97.522,KG,20230523,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Asthenia;Back pain;Dysstasia;Emotional distress;Fatigue;Gait disturbance;General physical health deterioration;Pain;Pollakiuria;Renal failure;Renal pain;Sepsis;Ureterolithiasis,207290144,OT,,,207290144,1,2006,2013,,,207290144,1,HIV infection
20858432,208584325,5,F,,20230419,20220521,20230428,EXP,,CA-009507513-2205CAN005476,MERCK,,54,YR,,M,Y,,,20230428,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,208584325,OT,,,,,,,,,208584325,1,HIV infection
20859502,208595023,3,F,20101001,20230614,20220523,20230619,EXP,,US-GILEAD-2022-0582516,GILEAD,,46,YR,A,M,Y,111.11,KG,20230619,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Back pain;Chronic kidney disease;Dysstasia;Emotional distress;Gait disturbance;Pain;Renal failure,208595023,OT,,,208595023,1,2006,201904,,,208595023,1,HIV infection
20861199,208611993,3,F,,20230502,20220523,20230509,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-039077,BRISTOL MYERS SQUIBB,,44,YR,A,M,Y,,,20230509,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Hospitalisation;Paranoia;Psychiatric decompensation;Psychomotor retardation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,208611993,HO,,,,,,,,,208611993,1,HIV infection
20871852,2087185210,10,F,,20230424,20220525,20230428,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2022082351,VIIV,,,,,,Y,,,20230428,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,2087185210,HO,,,,,,,,,2087185210,1,HIV infection
20871865,2087186510,10,F,,20230424,20220525,20230428,EXP,,CA-GLAXOSMITHKLINE-CA2022082351,GLAXOSMITHKLINE,,,,,,Y,,,20230428,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,2087186510,HO,,,,,,,,,2087186510,1,HIV infection
20883079,208830795,5,F,,20230424,20220527,20230427,EXP,,CA-BAUSCH-BL-2022-012991,BAUSCH AND LOMB,,54,YR,,M,Y,,,20230427,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,208830795,HO,,,,,,,,,208830795,1,Depression
20884066,208840667,7,F,,20230424,20220527,20230426,EXP,,CA-VIIV HEALTHCARE LIMITED-CA2022GSK084848,VIIV,,,,,,Y,,,20230426,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Incorrect route of product administration;Intentional product use issue;Loss of personal independence in daily activities;Prescribed overdose;Product use in unapproved indication,208840667,OT,,,,,,,,,208840667,1,HIV infection
20884074,208840747,7,F,,20230424,20220527,20230426,EXP,,CA-GLAXOSMITHKLINE-CA2022GSK084848,GLAXOSMITHKLINE,,,,,,Y,,,20230426,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Incorrect route of product administration;Intentional product use issue;Loss of personal independence in daily activities;Prescribed overdose;Product use in unapproved indication,208840747,DE,,,,,,,,,208840747,1,HIV infection
20892665,208926656,6,F,,20230612,20220531,20230615,EXP,,CA-ABBVIE-22K-028-4414704-00,ABBVIE,,54,YR,,M,Y,,,20230615,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,208926656,HO,,,,,,,,,208926656,1,HIV infection
20898441,208984415,5,F,,20230529,20220601,20230606,EXP,,CA-AUROBINDO-AUR-APL-2022-018761,AUROBINDO,,54,YR,,M,Y,,,20230606,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,208984415,OT,,,,,,,,,208984415,1,Psychotic disorder
20907220,209072205,5,F,,20230331,20220602,20230412,EXP,CA-ALLERGAN-2217864US,CA-ALLERGAN-2217864US,ALLERGAN,,,,,M,Y,,,20230412,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,209072205,HO,,,,,,,,,209072205,1,Psychotic disorder
20945155,2094515526,26,F,20100629,20230614,20220610,20230623,EXP,,GB-EMD Serono-E2B_90051865,EMD SERONO INC,,43,YR,A,F,Y,43,KG,20230623,,HP,GB,GB,EFAVIRENZ,Abortion spontaneous;Alanine aminotransferase increased;Aspartate aminotransferase increased;Caesarean section;Drug abuse;Exposure during pregnancy;Hepatic cytolysis;Intentional product use issue;Maternal exposure during pregnancy;Off label use;Ultrasound antenatal screen,2094515526,DE,,,2094515526,7,20100610,20100610,1,DAY,2094515526,1,Product used for unknown indication
20966859,2096685928,28,F,20100629,20230605,20220616,20230615,EXP,GB-AUROBINDO-AUR-APL-2018-033634,GB-STRIDES ARCOLAB LIMITED-2018SP005378,STRIDES,,43,YR,,F,Y,43,KG,20230615,,MD,GB,GB,EFAVIRENZ,Abortion spontaneous;Alanine aminotransferase increased;Aspartate aminotransferase increased;Caesarean section;Drug abuse;Hepatic cytolysis;Hydrops foetalis;Intentional product misuse;Intentional product use issue;Maternal exposure during pregnancy;Off label use,2096685928,CA,,,2096685928,1,20100610,20180205,4,MON,2096685928,1,HIV infection
20993425,209934256,6,F,,20230605,20220622,20230612,EXP,,CA-JNJFOC-20220629261,JOHNSON AND JOHNSON,,54,YR,A,M,Y,,,20230612,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,209934256,OT,,,,,,,,,209934256,1,Depression
21009064,2100906427,27,F,20120521,20230324,20220627,20230405,EXP,GB-EMA-DD-20180827-Ashwinihvp-120514,GB-Accord-109409,ACCORD,,43,YR,A,F,Y,43,KG,20230405,,HP,GB,GB,EFAVIRENZ,Abortion spontaneous;Alanine aminotransferase increased;Aspartate aminotransferase increased;Drug abuse;Hepatic cytolysis;Intentional product use issue;Maternal exposure during pregnancy,2100906427,OT,,,2100906427,4,20171006,20180205,123,DAY,2100906427,1,Supplementation therapy
21054689,210546892,2,F,20050801,20230410,20220707,20230417,EXP,,PT-MYLANLABS-2022M1050688,MYLAN,,54,YR,,M,Y,,,20230417,,MD,PT,PT,EFAVIRENZ,Adverse drug reaction;Drug ineffective;Pneumocystis jirovecii pneumonia;Rash,210546892,OT,,,210546892,1,200607,200504,,,210546892,1,HIV infection
21080303,210803033,3,F,20050801,20230404,20220714,20230415,EXP,,PT-AUROBINDO-AUR-APL-2022-025665,AUROBINDO,,54,YR,,M,Y,,,20230415,,MD,PT,PT,EFAVIRENZ,Adverse drug reaction;Drug ineffective;Pneumocystis jirovecii pneumonia;Rash,210803033,OT,,,210803033,2,200209,,,,210803033,1,HIV infection
21213995,212139952,2,F,,20230506,20220816,20230515,EXP,,SE-AUROBINDO-AUR-APL-2022-031768,AUROBINDO,"Soeria-Atmadja S, Amuge P, Nanzigu S, Bbuye D, Rubin J, Eriksen J, et al... Pretreatment HIV drug resistance predicts accumulation of new mutations in ART-na?ve Ugandan children. Acta Paediatrica. 2020;109:2706?2716",9,YR,,,Y,,,20230515,,HP,SE,UG,EFAVIRENZ,Pathogen resistance,212139952,OT,,,,,,,,,212139952,1,HIV infection
21214005,212140053,3,F,,20230506,20220816,20230515,EXP,,UG-AUROBINDO-AUR-APL-2022-031771,AUROBINDO,"Soeria-Atmadja S, Amuge P, Nanzigu S, Bbuye D, Rubin J, Eriksen J, et al... Pretreatment HIV drug resistance predicts accumulation of new mutations in ART-na?ve Ugandan children. Acta Paediatrica.. Acta Paediatrica.. 2020;109:2706-2716",5,YR,,,Y,,,20230515,,HP,SE,UG,EFAVIRENZ,Pathogen resistance,212140053,OT,,,,,,,,,212140053,1,HIV infection
21234498,212344982,2,F,,20230413,20220820,20230422,EXP,,CA-AUROBINDO-AUR-APL-2022-032494,AUROBINDO,,,,,M,Y,,,20230423,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction,212344982,HO,,,,,,,,,212344982,1,Product used for unknown indication
21236359,212363592,2,F,,20230417,20220822,20230430,EXP,,CA-AUROBINDO-AUR-APL-2022-033209,AUROBINDO,,54,YR,,M,Y,,,20230429,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,212363592,HO,,,,,,,,,212363592,1,HIV infection
21395027,213950272,2,F,,20230417,20220930,20230430,EXP,,CA-AUROBINDO-AUR-APL-2022-039545,AUROBINDO,,54,YR,,M,Y,,,20230429,,HP,CA,CA,EFAVIRENZ,Drug interaction;Psychiatric decompensation,213950272,OT,,,,,,,,,213950272,1,Depression
21408702,214087022,2,F,,20230420,20221004,20230501,EXP,,CA-AstraZeneca-2022A330151,ASTRAZENECA,,54,YR,,M,Y,,,20230501,,MD,CA,,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,214087022,HO,,,,,,,,,214087022,1,Depression
21411803,214118036,6,F,,20230302,20221005,20230626,EXP,,CA-MYLANLABS-2022M1110802,MYLAN,,54,YR,,M,Y,,,20230626,,HP,CA,CA,EFAVIRENZ,Anxiety;Depression suicidal;Depressive symptom;Drug interaction;Off label use;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,214118036,HO,,,214118036,1,2007,,,,214118036,1,Bipolar disorder
21532531,215325312,2,F,,20230427,20221101,20230511,EXP,,IN-CIPLA (EU) LIMITED-2022IN06312,CIPLA,"Lad SG, Pandey V, Kolhe K, Chauhan S, Gattani M, Sethiya P et.al. AIH in HIV: A Very Much Possible Entity. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY. 2022;12 (5):1388 to 1392",,,,,Y,,,20230511,,HP,IN,IN,EFAVIRENZ,Autoimmune hepatitis;Drug-induced liver injury,215325312,OT,,,,,,,,,215325312,1,HIV infection
21552956,215529563,3,F,20170101,20230627,20221104,20230630,EXP,,US-GILEAD-2022-0603472,GILEAD,,47,YR,A,F,Y,108.84,KG,20230630,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Arthralgia;Back pain;Blood cholesterol increased;Blood glucose increased;Bone demineralisation;Depression;Emotional distress;Gait disturbance;Hypertension;Osteopenia;Osteoporosis;Pain;Type 2 diabetes mellitus,215529563,OT,,,215529563,1,2001,201311,,,215529563,1,HIV infection
21583026,215830263,3,F,,20230426,20221111,20230508,EXP,CA-MHPD-E2B_05617673,CA-Accord-284705,ACCORD,,54,YR,A,M,Y,,,20230508,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,215830263,HO,,,,,,,,,215830263,1,Depression
21653751,2165375116,16,F,20120521,20230327,20221129,20230405,EXP,,GB-HORMOSAN PHARMA GMBH-2019-09098,LUPIN,,,,,,Y,,,20230405,,HP,GB,GB,EFAVIRENZ,Abortion spontaneous;Alanine aminotransferase increased;Aspartate aminotransferase increased;Drug abuse;Exposure during pregnancy;Hepatic cytolysis;Intentional product use issue;Maternal exposure during pregnancy;Off label use,2165375116,CA,,,2165375116,2,20171006,20180205,4,MON,2165375116,1,HIV infection
21699735,216997357,7,F,,20230619,20221208,20230623,EXP,,NVSC2022CA283120,NOVARTIS,,54,YR,,M,Y,,,20230621,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction;Incorrect route of product administration;Intentional product use issue;Prescribed overdose;Product use in unapproved indication,216997357,OT,,,,,,,,,216997357,1,HIV infection
21743058,217430582,2,F,,20230424,20221217,20230426,EXP,,CA-ABBVIE-4239153,ABBVIE,,44,YR,,M,Y,,,20230426,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor retardation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,217430582,HO,,,,,,,,,217430582,1,Bipolar disorder
21825988,218259882,2,F,,20230515,20230106,20230609,PER,,US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-004329,ACADIA PHARMACEUTICALS,,,,,M,Y,,,20230609,,CN,US,US,EFAVIRENZ,Behaviour disorder;Product dose omission issue;Treatment noncompliance,,,,,218259882,1,20200804,,,,218259882,1,Hallucination
21844892,218448922,2,F,20160301,20230517,20230110,20230522,EXP,,US-GILEAD-2023-0611878,GILEAD,,53,YR,A,M,Y,77.098,KG,20230522,,LW,US,US,SUSTIVA,Anhedonia;Anxiety;Back injury;Bone demineralisation;Chronic kidney disease;Emotional distress;Osteoporosis;Pain,218448922,OT,,,218448922,1,2004,201212,,,218448922,1,HIV infection
21903572,219035722,2,F,,20230404,20230124,20230417,EXP,,CA-MYLANLABS-2023M1006787,MYLAN,,,,A,M,Y,,,20230417,,CN,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction,219035722,HO,,,,,,,,,219035722,1,Product used for unknown indication
21903581,219035812,2,F,,20230606,20230124,20230614,EXP,,CA-MYLANLABS-2023M1006801,MYLAN,,54,YR,,M,Y,,,20230614,,CN,CA,CA,SUSTIVA,Depression;Drug interaction;Loss of personal independence in daily activities,219035812,OT,,,,,,,,,219035812,1,Bipolar disorder
21937868,219378682,2,F,,20230414,20230201,20230424,EXP,,CA-MYLANLABS-2023M1006243,MYLAN,,,,,M,Y,,,20230424,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,219378682,HO,,,,,,,,,219378682,1,Product used for unknown indication
21984954,219849544,4,F,20211101,20230530,20230213,20230605,EXP,,US-VIIV HEALTHCARE LIMITED-US2023AMR018948,VIIV,,,,,,Y,,,20230605,,HP,US,US,SUSTIVA,Hypokinesia;Injury;Intentional product misuse;Paralysis;Pyrexia;Thrombocytopenia;Wound infection,219849544,DS,,,219849544,1,2019,2019,,,219849544,1,HIV infection
22021535,220215352,2,F,,20230404,20230222,20230411,EXP,,NVSC2023CA035820,NOVARTIS,,,,,M,Y,,,20230411,,HP,CA,CA,SUSTIVA,Depression;Drug interaction,220215352,HO,,,,,,,,,220215352,1,Product used for unknown indication
22022015,220220154,4,F,,20230619,20230222,20230623,EXP,,NVSC2023CA037206,NOVARTIS,,54,YR,,M,Y,,,20230623,,CN,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,220220154,HO,,,,,,,,,220220154,1,Depression
22022503,220225033,3,F,,20230426,20230222,20230503,EXP,,NVSC2023CA035182,NOVARTIS,,44,YR,,M,Y,,,20230503,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor retardation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,220225033,OT,,,220225033,23,,,2,DAY,220225033,1,Depression
22100706,221007062,2,F,,20230421,20230316,20230506,EXP,,IN-MACLEODS PHARMA EU LTD-MAC2023040244,MACLEODS,"Joseph A, Cherian KE, Kapoor N, Paul TV.. Tenofovir-induced hypophosphatemic osteomalacia: how do bone mineral density, trabecular bone score and proximal hip geometry change with treatment?. Endocrinology Diabetes Metabolism Case Reports. 2023;22:0259",,,,,Y,,,20230505,,MD,IN,IN,EFAVIRENZ,Femoral neck fracture;Femur fracture;Hypokalaemia;Hypophosphataemic osteomalacia;Osteopenia;Osteoporosis;Renal tubular acidosis;Stress fracture,221007062,OT,,,221007062,1,,,12,YR,221007062,1,Antiretroviral therapy
22134963,221349633,3,F,,20230525,20230324,20230530,EXP,,NVSC2023CA062060,NOVARTIS,,54,YR,,M,Y,,,20230530,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Drug interaction,221349633,OT,,,,,,,,,221349633,1,Bipolar disorder
22138807,221388072,2,F,,20230411,20230327,20230426,EXP,,ES-MACLEODS PHARMACEUTICALS US LTD-MAC2023040379,MACLEODS,,,,,,Y,,,20230424,,HP,ES,ES,EFAVIRENZ,Disseminated tuberculosis;Drug interaction;Hepatotoxicity;Neurotoxicity,221388072,OT,,,,,,,,,221388072,1,Antiretroviral therapy
22140030,221400302,2,F,20140101,20230327,20230327,20230410,EXP,,ZW-CIPLA LTD.-2023ZW01605,CIPLA,"Mandikiyana Chirimuta LA, Pascoe MJ, Lowe S.. Emergent dolutegravir resistance in integrase-na?ve, treatment experienced patients from Zimbabwe. Southern African Journal of HIV Medicine. 2022;26;23(1):1435:1 to 3",,,,,Y,,,20230410,,HP,ZW,ZW,EFAVIRENZ,Multiple-drug resistance;Treatment noncompliance;Virologic failure,221400302,OT,,,221400302,1,201009,201501,,,221400302,1,HIV infection
22162331,221623313,3,F,,20230313,20230331,20230515,EXP,,ES-GILEAD-2023-0620975,GILEAD,"Kwon M, Bailen R, Balsalobre P, Jurado M, Bermudez A, Badiola J et al.. Allogeneic stem-cell transplantation in HIV-1-infected patients with high-risk hematological disorders.. AIDS. 2019;33(9):1441-1447. doi:10.1097\QAD.0000000000002209",,,A,,Y,,,20230515,,HP,ES,ES,EFAVIRENZ;EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Drug interaction;Hepatotoxicity;Neurotoxicity,221623313,OT,,,221623313,1,2008,,,,221623313,1,HIV infection
22163111,221631112,2,F,20230314,20230512,20230401,20230515,EXP,,BR-ROCHE-3322129,ROCHE,,27,YR,,F,Y,67,KG,20230515,,PH,BR,,EFAVIRENZ,Body temperature increased;Chills;Heart rate increased;Infusion related reaction;Oxygen saturation decreased;Tremor,221631112,HO,,,221631112,1,20230314,20230314,1,DAY,221631112,1,Product used for unknown indication
22165012,221650121,1,I,20050801,20230323,20230403,20230403,EXP,,PT-JNJFOC-20230359036,JOHNSON AND JOHNSON,,54,YR,A,M,Y,,,20230403,,HP,PT,PT,EFAVIRENZ,Adverse drug reaction;Drug ineffective;Pneumocystis jirovecii pneumonia;Rash,221650121,OT,,,221650121,2,200607,200504,,,221650121,1,HIV infection
22173828,221738281,1,I,20230101,20230323,20230404,20230404,EXP,,IT-009507513-2302ITA007959,MERCK,,59,YR,,F,Y,,,20230404,,MD,IT,IT,EFAVIRENZ,Pathogen resistance;Viral load increased;Viral mutation identified,221738281,OT,,,221738281,1,20210111,20210130,20,DAY,221738281,1,HIV infection
22176584,221765841,1,I,,20230327,20230405,20230405,EXP,,ZA-BRISTOL-MYERS SQUIBB COMPANY-2023-044903,BRISTOL MYERS SQUIBB,"Maharaj M, Levin M. Adverse drug reactions to antiretroviral combination treatments in a child. Current Allergy and Clinical Immunology. 2022 Sep 01;35(3): 180-1.",4,YR,C,F,Y,,,20230405,,HP,ZA,ZA,EFAVIRENZ,Type IV hypersensitivity reaction,221765841,OT,,,,,,,,,221765841,1,HIV infection
22188584,221885841,1,I,,20230327,20230409,20230409,EXP,,ZA-STRIDES ARCOLAB LIMITED-2023SP004808,STRIDES,"Munsami L, Schutte CM, de Villiers M, Hiesgen J.. Late-onset efavirenz toxicity: A descriptive study from Pretoria, South Africa.. South-Afr-J-HIV-Med. 2023;24(1)",,,,,Y,,,20230409,,HP,ZA,ZA,EFAVIRENZ,Encephalopathy;Quadriparesis;Toxicity to various agents,221885841,OT,,,,,,,,,221885841,1,HIV infection
22188585,221885851,1,I,,20230327,20230409,20230409,EXP,,ZA-STRIDES ARCOLAB LIMITED-2023SP004818,STRIDES,"Munsami L, Schutte CM, de Villiers M, Hiesgen J.. Late-onset efavirenz toxicity: A descriptive study from Pretoria, South Africa.. South-Afr-J-HIV-Med. 2023;24 (1)",,,,,Y,,,20230409,,HP,ZA,ZA,EFAVIRENZ,Cerebellar ataxia;Psychotic disorder;Toxicity to various agents,221885851,DE,,,,,,,,,221885851,1,HIV infection
22188586,221885861,1,I,,20230327,20230409,20230409,EXP,,ZA-STRIDES ARCOLAB LIMITED-2023SP004807,STRIDES,"Munsami L, Schutte CM, de Villiers M, Hiesgen J.. Late-onset efavirenz toxicity: A descriptive study from Pretoria, South Africa.. South-Afr-J-HIV-Med. 2023;24 (1)",,,,,Y,,,20230409,,HP,ZA,ZA,EFAVIRENZ,Cerebellar ataxia;Hemiparesis;Toxicity to various agents,221885861,OT,,,,,,,,,221885861,1,HIV infection
22192025,221920251,1,I,20210601,20230403,20230410,20230410,EXP,,CN-VIIV HEALTHCARE LIMITED-CN2023GSK049343,VIIV,"Zhang C, Qian C, Wang W, Chen Z, Lin Y, Sun M. AIDS with obesity, hypothyroidism and elevated serum creatinine: A case report. Frontiers in Medicine. 2023;10",,,,,Y,,,20230410,,HP,CN,CN,EFAVIRENZ,Asthenia;Blood creatinine increased;Bradykinesia;Chills;Condition aggravated;Constipation;Decreased appetite;Dry skin;Fatigue;Hypothyroidism;Left atrial enlargement;Left ventricular enlargement;Memory impairment;Muscular weakness;Oedema peripheral;Pallor;Pericardial effusion;Pleural effusion;Slow response to stimuli;Slow speech;Snoring;Somnolence;Thirst,221920251,HO,,,,,,,,,221920251,1,HIV infection
22192026,221920261,1,I,20190201,20230403,20230410,20230410,EXP,,NA-GSK-NA2023GSK048878,GLAXOSMITHKLINE,"Kakubu MAM, Bikinesi T, Katoto PDMC. Lamivudine induced pure red cell aplasia and HIV-1 drug resistance-associated mutations: a case report. Oxford Medical Case Reports. 2023;3:106-109",,,,,Y,,,20230410,,MD,,,EFAVIRENZ,Acquired immunodeficiency syndrome;Anaemia;Aplasia pure red cell;Fatigue;Oesophageal candidiasis;Pathogen resistance;Renal impairment;Renal injury;Therapy interrupted;Toxicity to various agents;Treatment failure;Treatment noncompliance;Viral mutation identified;Virologic failure,221920261,OT,,,221920261,1,201207,202002,,,221920261,1,HIV infection
22192027,221920271,1,I,20190201,20230403,20230410,20230410,EXP,,NA-VIIV HEALTHCARE LIMITED-NA2023GSK048878,VIIV,"Kakubu MAM, Bikinesi T, Katoto PDMC. Lamivudine induced pure red cell aplasia and HIV-1 drug resistance-associated mutations: a case report. Oxford Medical Case Reports. 2023;3:106-109",,,,,Y,,,20230410,,MD,,,EFAVIRENZ,Acquired immunodeficiency syndrome;Anaemia;Aplasia pure red cell;Fatigue;Oesophageal candidiasis;Pathogen resistance;Renal impairment;Renal injury;Therapy interrupted;Toxicity to various agents;Treatment failure;Treatment noncompliance;Viral mutation identified;Virologic failure,221920271,OT,,,221920271,1,201207,202002,,,221920271,1,HIV infection
22192030,221920301,1,I,20210601,20230403,20230410,20230410,EXP,,CN-GSK-CN2023GSK049343,GLAXOSMITHKLINE,"Zhang C, Qian C, Wang W, Chen Z, Lin Y, Sun M. AIDS with obesity, hypothyroidism and elevated serum creatinine: A case report. Frontiers in Medicine. 2023;10",,,,,Y,,,20230410,,HP,CN,CN,EFAVIRENZ,Asthenia;Blood creatinine increased;Bradykinesia;Chills;Condition aggravated;Constipation;Decreased appetite;Dry skin;Fatigue;Hypothyroidism;Left atrial enlargement;Left ventricular enlargement;Memory impairment;Muscular weakness;Oedema peripheral;Pallor;Pericardial effusion;Pleural effusion;Slow response to stimuli;Slow speech;Snoring;Somnolence;Thirst,221920301,HO,,,,,,,,,221920301,1,HIV infection
22206619,222066191,1,I,20141101,20230403,20230413,20230413,EXP,,HR-BRISTOL-MYERS SQUIBB COMPANY-2023-047779,BRISTOL MYERS SQUIBB,,66,YR,E,M,Y,,,20230413,,MD,HR,HR,EFAVIRENZ,Cardiac arrest;Condition aggravated;Hypertension;Myocardial infarction;Nephropathy,222066191,OT,,,222066191,1,200807,200808,1,MON,222066191,1,HIV infection
22209688,222096882,2,F,,20230523,20230414,20230603,EXP,,ZA-AUROBINDO-AUR-APL-2023-029515,AUROBINDO,"Munsami L, Schutte CM, de Villiers M, Hiesgen J. Late-onset efavirenz toxicity: A descriptive study from Pretoria, South Africa. South-Afr-J-HIV-Med. 2023;24No. 1.:1-6",,,A,,Y,,,20230603,,HP,ZA,ZA,EFAVIRENZ,Cerebellar ataxia;Psychotic disorder;Toxicity to various agents,222096882,DE,,,,,,,,,222096882,1,HIV infection
22214213,222142132,2,F,20170901,20230410,20230414,20230418,EXP,,PT-009507513-2304PRT004178,MERCK,,47,YR,,M,Y,,,20230418,,MD,PT,PT,EFAVIRENZ,Hyperphosphaturia;Hypertriglyceridaemia;Perforated ulcer;Proteinuria,222142132,OT,,,222142132,1,201308,,,,222142132,1,HIV infection
22216204,222162043,3,F,20120521,20230614,20230417,20230627,EXP,,GB-LUPIN EUROPE GMBH-2019-09099,LUPIN,,,,,,Y,,,20230627,,HP,GB,GB,EFAVIRENZ,Abortion spontaneous;Alanine aminotransferase increased;Aspartate aminotransferase increased;Drug abuse;Exposure during pregnancy;Hepatic cytolysis;Intentional product use issue;Maternal exposure during pregnancy;Off label use,222162043,CA,,,222162043,2,20171006,20180205,4,MON,222162043,1,HIV infection
22220716,222207161,1,I,20150101,20230411,20230418,20230418,EXP,,LV-JNJFOC-20201021251,JOHNSON AND JOHNSON,,45,YR,A,F,Y,,,20230418,,CN,LV,LV,EFAVIRENZ,Blood HIV RNA increased;Drug resistance;Exposure during pregnancy;Hyperhidrosis;Therapy change,222207161,OT,,,222207161,1,2019,,,,222207161,1,HIV infection
22223425,222234251,1,I,,20230413,20230418,20230418,EXP,,BR-VIIV HEALTHCARE LIMITED-BR2023GSK055711,VIIV,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222234251,OT,,,,,,,,,222234251,1,HIV infection
22223426,222234261,1,I,,20230413,20230418,20230418,EXP,,BR-GSK-BR2023GSK055711,GLAXOSMITHKLINE,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222234261,OT,,,,,,,,,222234261,1,HIV infection
22223512,222235121,1,I,,20230413,20230418,20230418,EXP,,BR-VIIV HEALTHCARE LIMITED-BR2023GSK055725,VIIV,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222235121,OT,,,,,,,,,222235121,1,HIV infection
22223513,222235131,1,I,,20230413,20230418,20230418,EXP,,BR-GSK-BR2023GSK055725,GLAXOSMITHKLINE,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222235131,OT,,,,,,,,,222235131,1,HIV infection
22225062,222250621,1,I,,20230413,20230418,20230418,EXP,,BR-GSK-BR2023GSK055726,GLAXOSMITHKLINE,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222250621,OT,,,,,,,,,222250621,1,HIV infection
22225063,222250631,1,I,,20230413,20230418,20230418,EXP,,BR-VIIV HEALTHCARE LIMITED-BR2023GSK055726,VIIV,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222250631,OT,,,,,,,,,222250631,1,HIV infection
22225111,222251111,1,I,,20230413,20230418,20230418,EXP,,BR-VIIV HEALTHCARE LIMITED-BR2023GSK055732,VIIV,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222251111,OT,,,,,,,,,222251111,1,HIV infection
22225112,222251121,1,I,,20230413,20230418,20230418,EXP,,BR-GSK-BR2023GSK055732,GLAXOSMITHKLINE,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222251121,OT,,,,,,,,,222251121,1,HIV infection
22225402,222254021,1,I,,20230413,20230418,20230418,EXP,,BR-GSK-BR2023GSK055750,GLAXOSMITHKLINE,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222254021,OT,,,,,,,,,222254021,1,HIV infection
22225403,222254031,1,I,,20230413,20230418,20230418,EXP,,BR-VIIV HEALTHCARE LIMITED-BR2023GSK055750,VIIV,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222254031,OT,,,,,,,,,222254031,1,HIV infection
22225469,222254691,1,I,,20230413,20230418,20230418,EXP,,BR-VIIV HEALTHCARE LIMITED-BR2023GSK056209,VIIV,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222254691,OT,,,,,,,,,222254691,1,HIV infection
22225472,222254721,1,I,,20230413,20230418,20230418,EXP,,BR-VIIV HEALTHCARE LIMITED-BR2023GSK055751,VIIV,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222254721,OT,,,,,,,,,222254721,1,HIV infection
22225473,222254731,1,I,,20230413,20230418,20230418,EXP,,BR-VIIV HEALTHCARE LIMITED-BR2023GSK055761,VIIV,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222254731,OT,,,,,,,,,222254731,1,HIV infection
22225474,222254741,1,I,,20230413,20230418,20230418,EXP,,BR-VIIV HEALTHCARE LIMITED-BR2023GSK055760,VIIV,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222254741,OT,,,,,,,,,222254741,1,HIV infection
22225476,222254761,1,I,,20230413,20230418,20230418,EXP,,BR-GSK-BR2023GSK055751,GLAXOSMITHKLINE,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222254761,OT,,,,,,,,,222254761,1,HIV infection
22225477,222254771,1,I,,20230413,20230418,20230418,EXP,,BR-GSK-BR2023GSK055761,GLAXOSMITHKLINE,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222254771,OT,,,,,,,,,222254771,1,HIV infection
22225479,222254791,1,I,,20230413,20230418,20230418,EXP,,BR-GSK-BR2023GSK056209,GLAXOSMITHKLINE,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222254791,OT,,,,,,,,,222254791,1,HIV infection
22225480,222254801,1,I,,20230413,20230418,20230418,EXP,,BR-GSK-BR2023GSK055760,GLAXOSMITHKLINE,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222254801,OT,,,,,,,,,222254801,1,HIV infection
22225507,222255071,1,I,,20230413,20230418,20230418,EXP,,BR-VIIV HEALTHCARE LIMITED-BR2023GSK056211,VIIV,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222255071,OT,,,,,,,,,222255071,1,HIV infection
22225508,222255081,1,I,,20230413,20230418,20230418,EXP,,BR-VIIV HEALTHCARE LIMITED-BR2023GSK056210,VIIV,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222255081,OT,,,,,,,,,222255081,1,HIV infection
22225509,222255091,1,I,,20230413,20230418,20230418,EXP,,BR-VIIV HEALTHCARE LIMITED-BR2023GSK056272,VIIV,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222255091,OT,,,,,,,,,222255091,1,HIV infection
22225510,222255101,1,I,,20230413,20230418,20230418,EXP,,BR-VIIV HEALTHCARE LIMITED-BR2023GSK056212,VIIV,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222255101,OT,,,,,,,,,222255101,1,HIV infection
22225511,222255111,1,I,,20230413,20230418,20230418,EXP,,BR-GSK-BR2023GSK056210,GLAXOSMITHKLINE,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222255111,OT,,,,,,,,,222255111,1,HIV infection
22225512,222255121,1,I,,20230413,20230418,20230418,EXP,,BR-GSK-BR2023GSK056272,GLAXOSMITHKLINE,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222255121,OT,,,,,,,,,222255121,1,HIV infection
22225513,222255131,1,I,,20230413,20230418,20230418,EXP,,BR-GSK-BR2023GSK056212,GLAXOSMITHKLINE,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222255131,OT,,,,,,,,,222255131,1,HIV infection
22225514,222255141,1,I,,20230413,20230418,20230418,EXP,,BR-GSK-BR2023GSK056211,GLAXOSMITHKLINE,,,,,,Y,,,20230418,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222255141,OT,,,,,,,,,222255141,1,HIV infection
22227354,222273541,1,I,,20230410,20230419,20230419,EXP,,DE-MYLANLABS-2023M1041180,MYLAN,"Evers S, Buchheister A, Reichelt D, Husstedt IW, Frese A. Botulinum Toxin A Treatment in HIV Infected Patients-A Long-Term Observational Study. J-Clin-Med 2022;11:2197.",54,YR,,M,Y,,,20230419,,HP,DE,DE,EFAVIRENZ,Drug ineffective for unapproved indication;Off label use,222273541,OT,,,,,,,,,222273541,1,Tremor
22227500,222275001,1,I,20170901,20230405,20230419,20230419,EXP,,ZA-CIPLA (EU) LIMITED-2023ZA02014,CIPLA,"Khan A, Pillay M, Chimukangara B, Gounder L, Manyana S, Francois KL et al.. Identification of HIV-1 subtype CRF18_cpx in a patient with multidrug resistance in KwaZulu-Natal, South Africa: An epidemiological worry?. Journal of Clinical Virology Plus. 2023;1 to 7",,,,,Y,,,20230419,,HP,ZA,ZA,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Diarrhoea;Multiple-drug resistance;Normochromic normocytic anaemia;Treatment noncompliance;Virologic failure,222275001,HO,,,222275001,1,20170109,20181204,694,DAY,222275001,1,HIV infection
22227810,222278101,1,I,,20230413,20230419,20230419,EXP,,BR-GSK-BR2023GSK056273,GLAXOSMITHKLINE,,,,,,Y,,,20230419,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222278101,OT,,,,,,,,,222278101,1,HIV infection
22227811,222278111,1,I,,20230413,20230419,20230419,EXP,,BR-VIIV HEALTHCARE LIMITED-BR2023GSK056273,VIIV,,,,,,Y,,,20230419,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222278111,OT,,,,,,,,,222278111,1,HIV infection
22227976,222279761,1,I,,20230413,20230419,20230419,EXP,,BR-VIIV HEALTHCARE LIMITED-BR2023GSK056275,VIIV,,,,,,Y,,,20230419,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222279761,OT,,,,,,,,,222279761,1,HIV infection
22227977,222279771,1,I,,20230413,20230419,20230419,EXP,,BR-GSK-BR2023GSK056275,GLAXOSMITHKLINE,,,,,,Y,,,20230419,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222279771,OT,,,,,,,,,222279771,1,HIV infection
22228079,222280791,1,I,,20230413,20230419,20230419,EXP,,BR-VIIV HEALTHCARE LIMITED-BR2023GSK056377,VIIV,,,,,,Y,,,20230419,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222280791,OT,,,,,,,,,222280791,1,HIV infection
22228080,222280801,1,I,,20230413,20230419,20230419,EXP,,BR-GSK-BR2023GSK056377,GLAXOSMITHKLINE,,,,,,Y,,,20230419,,HP,BR,BR,EFAVIRENZ,Pathogen resistance;Viral mutation identified,222280801,OT,,,,,,,,,222280801,1,HIV infection
22229657,222296571,1,I,20180126,20230411,20230419,20230419,EXP,,ES-TAKEDA-DE201826908,TAKEDA,,44,YR,,M,Y,,,20230419,,HP,ES,ES,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Tibia fracture,222296571,HO,,,222296571,1,20081030,20160714,8,DAY,222296571,1,Factor VIII deficiency
22230708,222307081,1,I,20210101,20230417,20230420,20230420,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-2023-055143,BRISTOL MYERS SQUIBB,"Zhang C, Qian C, Wang W, Chen Z, Lin Y, Sun M. AIDS with obesity, hypothyroidism and elevated serum creatinine: a case report. Frontiers in Medicine. 2023 Mar 14;10:1-4. doi:10.3389/fmed.2023.1090659.",30,YR,A,M,Y,,,20230420,,HP,CN,CN,EFAVIRENZ,Blood creatinine increased;Hypothyroidism;Obesity,222307081,OT,,,,,,,,,222307081,1,Acquired immunodeficiency syndrome
22230901,222309011,1,I,,20230405,20230420,20230420,EXP,,NA-MACLEODS PHARMACEUTICALS US LTD-MAC2023040810,MACLEODS,"Kakubu MA, Bikinesi T, Katoto PD. Lamivudine induced pure red cell aplasia and HIV-1 drug resistance-associated mutations: a case report. Oxford Medical Case Reports. 2023;3:106-109",,,,,Y,,,20230418,,HP,,,EFAVIRENZ,Aplasia pure red cell;Drug resistance mutation;Renal injury;Treatment failure;Treatment noncompliance,222309011,OT,,,,,,,,,222309011,1,HIV infection
22237729,222377293,3,F,20170901,20230518,20230421,20230523,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-2023-055121,BRISTOL MYERS SQUIBB,,47,YR,A,M,Y,,,20230523,,MD,PT,PT,EFAVIRENZ,Hyperphosphaturia;Hypertriglyceridaemia;Perforated ulcer;Proteinuria,222377293,OT,,,222377293,1,201308,,,,222377293,1,HIV infection
22243522,222435221,1,I,20230101,20230308,20230424,20230424,EXP,,IT-AUROBINDO-AUR-APL-2023-011403,AUROBINDO,,59,YR,,F,Y,,,20230423,,MD,IT,IT,EFAVIRENZ,Drug resistance;Pathogen resistance;Viral load increased;Viral mutation identified;Virologic failure,222435221,OT,,,222435221,1,2009,20210130,20,DAY,222435221,1,Antiviral treatment
22245412,222454121,1,I,,20230410,20230424,20230424,EXP,,DE-drreddys-LIT/GER/23/0164301,DR REDDYS,"Evers S, Buchheister A, Reichelt D, Husstedt I, Frese A. Botulinum Toxin A Treatment in HIV Infected Patients-A Long-Term Observational Study. J Clin Med. 2022;11:2197-2197. doi:10.3390/jcm11082197",54,YR,A,M,Y,,,20230424,,HP,DE,DE,EFAVIRENZ,Drug ineffective for unapproved indication;Head titubation;Hemiparesis;Product use in unapproved indication;Progressive multifocal leukoencephalopathy,222454121,OT,,,,,,,,,222454121,1,HIV infection CDC category C
22245877,222458771,1,I,20160101,20230417,20230424,20230424,EXP,,PT-GSK-PT2023EME057134,GLAXOSMITHKLINE,,,,,,Y,,,20230424,,MD,PT,PT,EFAVIRENZ,Dyslipidaemia;Glomerular filtration rate increased;Lipids increased;Nervous system disorder;Renal impairment,222458771,OT,,,222458771,1,2012,2016,,,222458771,1,HIV infection
22245878,222458781,1,I,20160101,20230417,20230424,20230424,EXP,,PT-VIIV HEALTHCARE LIMITED-PT2023EME057134,VIIV,,,,,,Y,,,20230424,,MD,PT,PT,EFAVIRENZ,Dyslipidaemia;Glomerular filtration rate increased;Lipids increased;Nervous system disorder;Renal impairment,222458781,OT,,,222458781,1,2012,2016,,,222458781,1,HIV infection
22246460,222464602,2,F,,20230417,20230424,20230503,EXP,,IN-GILEAD-2023-0624846,GILEAD,"Joseph A., Cherian K, Kapoor N., Paul T. Tenofovir-induced hypophosphatemic osteomalacia: how do bone mineral density, trabecular bone score and proximal hip geometry change with treatment?. Endocrinology, Diabetes and Metabolism Case Reports. 2023;2023(1):unk. doi:10.1530/EDM-22-0259",46,YR,A,F,Y,,,20230503,,HP,IN,IN,EFAVIRENZ,Hypophosphataemic osteomalacia;Renal tubular acidosis,222464602,OT,,,,,,,,,222464602,1,HIV infection
22255608,222556081,1,I,,20230421,20230426,20230426,EXP,,GB-MYLANLABS-2023M1044100,MYLAN,,,,A,F,Y,,,20230426,,CN,GB,GB,EFAVIRENZ,Suicidal ideation,222556081,OT,,,,,,,,,222556081,1,HIV infection
22256075,222560751,1,I,,20230424,20230426,20230426,EXP,,US-GILEAD-2023-0625877,GILEAD,,,,A,F,Y,,,20230426,,CN,US,US,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Bone density decreased;Lower limb fracture;Osteoporosis,222560751,OT,,,,,,,,,222560751,1,HIV infection
22258654,222586541,1,I,20210101,20230420,20230427,20230427,EXP,,PT-VIIV HEALTHCARE LIMITED-PT2023EME058556,VIIV,,,,,,Y,,,20230427,,MD,PT,PT,EFAVIRENZ,Benign prostatic hyperplasia;Hypertension;Lipids increased;Renal function test abnormal;Urinary retention,222586541,OT,,,222586541,1,2015,,,,222586541,1,HIV infection
22258677,222586771,1,I,20210101,20230420,20230427,20230427,EXP,,PT-GSK-PT2023EME058556,GLAXOSMITHKLINE,,,,,,Y,,,20230427,,MD,PT,PT,EFAVIRENZ,Benign prostatic hyperplasia;Hypertension;Lipids increased;Renal function test abnormal;Urinary retention,222586771,OT,,,222586771,1,2015,,,,222586771,1,HIV infection
22259303,222593031,1,I,,20230420,20230427,20230427,EXP,,PT-VIIV HEALTHCARE LIMITED-PT2023EME058634,VIIV,,,,,,Y,,,20230427,,MD,PT,PT,EFAVIRENZ,Diabetes mellitus;Dyslipidaemia;Gastric disorder;Hypersensitivity;Hypertension;Lipodystrophy acquired;Paraesthesia,222593031,OT,,,222593031,1,1996,,,,222593031,1,HIV infection
22259304,222593041,1,I,,20230420,20230427,20230427,EXP,,PT-GSK-PT2023EME058634,GLAXOSMITHKLINE,,,,,,Y,,,20230427,,MD,PT,PT,EFAVIRENZ,Diabetes mellitus;Dyslipidaemia;Gastric disorder;Hypersensitivity;Hypertension;Lipodystrophy acquired;Paraesthesia,222593041,OT,,,222593041,1,1996,,,,222593041,1,HIV infection
22261125,222611251,1,I,,20230424,20230427,20230427,EXP,,CA-BAUSCH-BL-2023-006499,BAUSCH AND LOMB,,54,YR,,M,Y,,,20230427,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,222611251,HO,,,,,,,,,222611251,1,Product used for unknown indication
22261127,222611271,1,I,,20230424,20230427,20230427,EXP,,CA-BAUSCH-BL-2023-006503,BAUSCH AND LOMB,,44,YR,,M,Y,,,20230427,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor retardation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,222611271,HO,,,,,,,,,222611271,1,Depression
22261133,222611331,1,I,,20230424,20230427,20230427,EXP,,CA-BAUSCH-BL-2023-006496,BAUSCH AND LOMB,,54,YR,,M,Y,,,20230427,,HP,CA,CA,EFAVIRENZ,Depression;Drug interaction;Intentional product use issue;Loss of personal independence in daily activities;Prescribed overdose,222611331,DE,,,,,,,,,222611331,1,Bipolar disorder
22262511,222625111,1,I,,20230419,20230428,20230428,EXP,,CA-009507513-2304CAN008438,MERCK,,54,YR,,M,Y,,,20230428,,HP,CA,CA,EFAVIRENZ,Depression;Drug interaction;Intentional product use issue;Loss of personal independence in daily activities;Prescribed overdose,222625111,DE,,,,,,,,,222625111,1,HIV infection
22262576,222625761,1,I,20160101,20230427,20230428,20230428,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-2023-060819,BRISTOL MYERS SQUIBB,,,,E,M,Y,,,20230428,,MD,PT,PT,EFAVIRENZ,Dyslipidaemia;Glomerular filtration rate increased;Lipids increased;Nervous system disorder;Renal impairment,222625761,OT,,,222625761,1,2012,2016,,,222625761,1,HIV infection
22263380,222633801,1,I,,20230420,20230428,20230428,EXP,,CA-AstraZeneca-2023A095376,ASTRAZENECA,,54,YR,,M,Y,,,20230428,,MD,CA,,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,222633801,HO,,,,,,,,,222633801,1,Bipolar I disorder
22263785,222637851,1,I,,20230421,20230428,20230428,EXP,,FR-GSK-FR2023059022,GLAXOSMITHKLINE,,,,,,Y,,,20230428,,CN,FR,FR,EFAVIRENZ,Cardiac discomfort;Choking;Dyspnoea;Labelled drug-drug interaction issue;Product use in unapproved indication,222637851,OT,,,,,,,,,222637851,1,HIV infection
22264729,222647291,1,I,,20230420,20230428,20230428,EXP,,CA-AstraZeneca-2023A095426,ASTRAZENECA,,44,YR,,M,Y,,,20230428,,MD,CA,,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor retardation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,222647291,OT,,,,,,,,,222647291,1,Product used for unknown indication
22264846,222648461,1,I,,20230423,20230428,20230428,EXP,,CN-VIIV HEALTHCARE LIMITED-CN2023APC059135,VIIV,,,,,,Y,,,20230428,,MD,CN,CN,EFAVIRENZ,Pathogen resistance;Virologic failure,222648461,OT,,,,,,,,,222648461,1,HIV infection
22264848,222648481,1,I,,20230423,20230428,20230428,EXP,,CN-GSK-CN2023APC059135,GLAXOSMITHKLINE,,,,,,Y,,,20230428,,MD,CN,CN,EFAVIRENZ,Pathogen resistance;Virologic failure,222648481,OT,,,,,,,,,222648481,1,HIV infection
22267571,222675712,2,F,20170901,20230518,20230430,20230528,EXP,,PT-AUROBINDO-AUR-APL-2023-031894,AUROBINDO,,47,YR,,M,Y,,,20230528,,MD,PT,PT,EFAVIRENZ,Hyperphosphaturia;Hypertriglyceridaemia;Perforated ulcer;Proteinuria,222675712,OT,,,222675712,1,201308,,,,222675712,1,HIV infection
22267893,222678931,1,I,,20230426,20230430,20230430,EXP,,NVSC2023CA097011,NOVARTIS,,54,YR,,M,Y,,,20230429,,HP,CA,CA,EFAVIRENZ,Depression;Drug interaction;Intentional product use issue;Prescribed overdose,222678931,DE,,,,,,,,,222678931,1,Bipolar disorder
22271438,222714381,1,I,20160101,20230427,20230501,20230501,EXP,,PT-ABBVIE-4744607,ABBVIE,,,,,M,Y,,,20230501,,MD,PT,PT,EFAVIRENZ,Dyslipidaemia;Glomerular filtration rate increased;Lipids increased;Nervous system disorder;Renal impairment,222714381,OT,,,222714381,1,2016,2016,,,222714381,1,HIV infection
22271844,222718442,2,F,,20230505,20230502,20230511,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-2023-061732,BRISTOL MYERS SQUIBB,,,,,F,Y,,,20230511,,CN,PT,PT,EFAVIRENZ,Diabetes mellitus;Dyslipidaemia;Gastric disorder;Hypersensitivity;Hypertension;Lipodystrophy acquired;Paraesthesia,222718442,OT,,,222718442,1,2001,,,,222718442,1,HIV infection
22271913,222719131,1,I,20210101,20230428,20230502,20230502,EXP,,PT-BRISTOL-MYERS SQUIBB COMPANY-2023-061750,BRISTOL MYERS SQUIBB,,,,E,M,Y,,,20230502,,MD,PT,PT,EFAVIRENZ,Benign prostatic hyperplasia;Hypertension;Lipids increased;Renal function test abnormal;Urinary retention,222719131,OT,,,222719131,1,2015,,,,222719131,1,HIV infection
22278141,222781411,1,I,,20230424,20230503,20230503,EXP,,CA-APOTEX-2023AP007608,APOTEX,,54,YR,,M,Y,,,20230503,,HP,CA,CA,EFAVIRENZ,Depression;Drug interaction;Intentional product use issue;Loss of personal independence in daily activities;Prescribed overdose,222781411,DE,,,,,,,,,222781411,1,Bipolar disorder
22278422,222784221,1,I,,20230424,20230503,20230503,EXP,,CA-APOTEX-2023AP007606,APOTEX,,44,YR,,M,Y,,,20230503,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor retardation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,222784221,OT,,,,,,,,,222784221,1,HIV infection
22278700,222787001,1,I,,20230424,20230503,20230503,EXP,,CA-APOTEX-2023AP007642,APOTEX,,54,YR,,M,Y,,,20230503,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Product use in unapproved indication;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,222787001,HO,,,,,,,,,222787001,1,Psychotic disorder
22281625,222816251,1,I,,20230501,20230504,20230504,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-2023-062619,BRISTOL MYERS SQUIBB,,60,YR,A,M,Y,,,20230504,,CN,FR,FR,EFAVIRENZ,Cardiac discomfort;Choking;Dyspnoea;Labelled drug-drug interaction issue,222816251,OT,,,,,,,,,222816251,1,HIV infection
22286583,222865831,1,I,,20230421,20230505,20230505,EXP,,GB-AUROBINDO-AUR-APL-2023-032945,AUROBINDO,,,,A,F,Y,,,20230505,,CN,GB,GB,EFAVIRENZ,Suicidal ideation,222865831,OT,,,,,,,,,222865831,1,HIV infection
22291479,222914791,1,I,,20230421,20230506,20230506,EXP,,GB-MACLEODS PHARMA EU LTD-MAC2023041115,MACLEODS,,,,,,Y,,,20230506,,CN,GB,GB,EFAVIRENZ,Suicidal ideation,222914791,OT,,,,,,,,,222914791,1,HIV infection
22294280,222942801,1,I,20160101,20230501,20230508,20230508,EXP,,PT-JNJFOC-20230503835,JOHNSON AND JOHNSON,,,,E,M,Y,,,20230508,,MD,PT,PT,EFAVIRENZ,Dyslipidaemia;Glomerular filtration rate increased;Lipids increased;Nervous system disorder;Renal impairment,222942801,OT,,,222942801,1,2012,2016,,,222942801,1,HIV infection
22295092,222950921,1,I,,20230428,20230508,20230508,EXP,,CA-TEVA-2023-CA-2883508,TEVA,,54,YR,A,M,Y,,,20230508,,CN,CA,CA,EFAVIRENZ,Drug interaction;Psychiatric decompensation,222950921,OT,,,,,,,,,222950921,1,Depression
22298122,222981221,1,I,,20230502,20230509,20230509,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-107208,BRISTOL MYERS SQUIBB,,54,YR,A,M,Y,,,20230509,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Hospitalisation;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,222981221,HO,,,,,,,,,222981221,1,HIV infection
22298796,222987961,1,I,,20220621,20230509,20230509,EXP,,IN-BRISTOL-MYERS SQUIBB COMPANY-2023-065324,BRISTOL MYERS SQUIBB,"Sivagourounadin K, Rajendran P, Selvarajan S, Ganesapandian M. Agreement among different scales for causality assessment in drug-induced stevens-johnson syndrome and toxic epidermal necrolysis. Current Drug Safety. 2022;17(1):40-6. doi:10.2174/1574886316666210611160123.",44,YR,A,F,Y,,,20230509,,MD,IN,IN,EFAVIRENZ,Stevens-Johnson syndrome;Toxic epidermal necrolysis,222987961,OT,,,,,,,,,222987961,1,Pneumocystis jirovecii pneumonia
22300406,223004061,1,I,,20230502,20230509,20230509,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2023-063721,BRISTOL MYERS SQUIBB,,44,YR,A,M,Y,,,20230509,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Hospitalisation;Off label use;Paranoia;Psychiatric decompensation;Psychomotor retardation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,223004061,HO,,,,,,,,,223004061,1,HIV infection
22302723,223027231,1,I,20210101,20230428,20230510,20230510,EXP,,PT-AUROBINDO-AUR-APL-2023-034899,AUROBINDO,,,,E,M,Y,,,20230510,,MD,PT,PT,EFAVIRENZ,Benign prostatic hyperplasia;Hypertension;Lipids increased;Renal function test abnormal;Urinary retention,223027231,OT,,,223027231,1,2015,,,,223027231,1,HIV infection
22305380,223053801,1,I,,20230504,20230510,20230510,EXP,,PT-MYLANLABS-2023M1048151,MYLAN,,,,,F,Y,,,20230510,,MD,PT,PT,EFAVIRENZ,Diabetes mellitus;Dyslipidaemia;Gastric disorder;Hypersensitivity;Hypertension;Lipodystrophy acquired;Paraesthesia,223053801,OT,,,223053801,1,2001,,,,223053801,1,HIV infection
22305831,223058311,1,I,,20230428,20230511,20230511,EXP,,PT-AUROBINDO-AUR-APL-2023-034901,AUROBINDO,,,,,F,Y,,,20230511,,MD,PT,PT,EFAVIRENZ,Diabetes mellitus;Dyslipidaemia;Gastric disorder;Hypersensitivity;Hypertension;Lipodystrophy acquired;Paraesthesia,223058311,OT,,,223058311,1,2001,,,,223058311,1,HIV infection
22305946,223059461,1,I,,20230429,20230511,20230511,EXP,,FR-AUROBINDO-AUR-APL-2023-035329,AUROBINDO,,60,YR,,M,Y,,,20230511,,CN,FR,FR,EFAVIRENZ,Cardiac discomfort;Choking;Dyspnoea;Labelled drug-drug interaction issue;Product use in unapproved indication,223059461,OT,,,,,,,,,223059461,1,HIV infection
22310847,223108471,1,I,,20230505,20230511,20230511,EXP,,FR-MYLANLABS-2023M1048249,MYLAN,,60,YR,,M,Y,,,20230511,,CN,FR,FR,EFAVIRENZ,Cardiac discomfort;Choking;Dyspnoea;Labelled drug-drug interaction issue;Product use in unapproved indication,223108471,OT,,,,,,,,,223108471,1,HIV infection
22312570,223125701,1,I,,20230510,20230512,20230512,EXP,,GB-CIPLA LTD.-2023GB02522,CIPLA,,,,,,Y,,,20230512,,CN,GB,GB,EFAVIRENZ,Suicidal ideation,223125701,OT,,,,,,,,,223125701,1,HIV infection
22313192,223131921,1,I,20180101,20230501,20230512,20230512,EXP,,MM-CIPLA LTD.-2023MM02463,CIPLA,"Lin KS, Nyein PP, Win S.. Drug-induced immune hemolytic anemia because of Efavirenz: A case report. AIDS. 2020;34 (2):326 to 328",,,,,Y,,,20230512,,HP,MM,MM,EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE,Haemolytic anaemia,223131921,HO,,,223131921,1,2015,20180123,,,223131921,1,HIV infection
22313201,223132011,1,I,,20230511,20230512,20230512,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-236859",BOEHRINGER INGELHEIM,,61,YR,A,M,Y,,,20230512,,CN,DE,DE,EFAVIRENZ,Major depression;Nervous system disorder;Viral mutation identified,223132011,OT,,,223132011,1,20001115,20010115,2,MON,223132011,1,HIV infection CDC category B
22320046,223200461,1,I,,20230511,20230515,20230515,EXP,,NVSC2023DE108062,NOVARTIS,,61,YR,,M,Y,,,20230515,,MD,DE,DE,EFAVIRENZ,Major depression;Nervous system disorder;Viral mutation identified,223200461,OT,,,223200461,1,20000601,20010115,229,DAY,223200461,1,HIV infection CDC category B
22321206,223212061,1,I,,20230503,20230515,20230515,EXP,,TH-VIIV HEALTHCARE LIMITED-TH2023GSK064336,VIIV,"Anuroj K, Chongbanyatcharoen S, Chiencharoenthanakij R. Severe Anemia: A Case Report of an Uncommon Precipitant of Schizophrenia Relapse. Journal of Blood Medicine. 2023;14:329-336",,,,,Y,,,20230510,,HP,TH,TH,EFAVIRENZ,Anaemia;Aplasia pure red cell;Fatigue;Headache;Irritability;Psychotic disorder;Schizophrenia;Slow response to stimuli;Somatic symptom disorder;Temperature intolerance,223212061,OT,,,223212061,5,2014,,,,223212061,1,HIV infection
22330837,223308371,1,I,,20230214,20230517,20230517,EXP,,ZA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381133,RANBAXY,"Aja-Okorie U, Ngene NC. Atypical preeclampsia-eclampsia syndrome at 18 weeks of gestation: A case report. Case Rep Women Health. 2022;36:e00470",,,,,Y,0.2,KG,20230517,,HP,ZA,ZA,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Foetal exposure during pregnancy;Premature baby,223308371,OT,,,,,,,,,223308371,1,HIV infection
22330846,223308461,1,I,,20230214,20230517,20230517,EXP,,ZA-SUN PHARMACEUTICAL INDUSTRIES LTD-2023R1-381131,RANBAXY,"Aja-Okorie U, Ngene NC. Atypical preeclampsia-eclampsia syndrome at 18 weeks of gestation: A case report. Case Rep Women Health. 2022;36:e00470",29,YR,,F,Y,,,20230517,,HP,ZA,ZA,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Exposure during pregnancy;HELLP syndrome;Posterior reversible encephalopathy syndrome;Premature delivery,223308461,OT,,,,,,,,,223308461,1,HIV infection
22335379,223353791,1,I,,20230509,20230518,20230518,EXP,,TZ-STRIDES ARCOLAB LIMITED-2023SP007053,STRIDES,"Mandari S, Aslan S, Deodatus S, Nyundo A.. Delusional Infestation: A case of Ekbom syndrome in an elderly woman with a long history of HIV.. Clin-Case-Rep.. 2023;11(3):no pagination",70,YR,,F,Y,,,20230518,,HP,TZ,TZ,EFAVIRENZ,Delusion of parasitosis,223353791,OT,,,,,,,,,223353791,1,HIV infection
22335823,223358231,1,I,,20230508,20230518,20230518,EXP,,DE-AUROBINDO-AUR-APL-2023-036404,AUROBINDO,,61,YR,,M,Y,,,20230518,,MD,DE,DE,EFAVIRENZ,Major depression;Nervous system disorder;Viral mutation identified,223358231,OT,,,223358231,1,20000601,20001115,167,DAY,223358231,1,HIV infection CDC category B
22335837,223358371,1,I,20210101,20230507,20230518,20230518,EXP,,IN-HETERO-HET2023IN01272,HETERO,"Choudhary S, Rangasamy K, Naidu S, Sachdeva RK, Sharma A. Subtrochanteric Pathological Femur Fracture in an HIV-Positive Patient  on Tenofovir-based antiretroviral therapy: A Case Report and Review of  the Literature. Journal of Orthopaedic Case Reports. 2023;13(2):14-20",40,YR,,F,Y,,,20230518,,MD,IN,IN,EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE,Femur fracture;Osteomalacia,223358371,HO,,,,,,,,,223358371,1,HIV infection
22338353,223383532,2,F,,20230419,20230518,20230526,EXP,,GB-GILEAD-2023-0625168,GILEAD,,,,,M,Y,,,20230526,,MD,GB,GB,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Agitation;Diabetes mellitus;Insomnia;Weight increased,223383532,OT,,,223383532,1,2013,2013,8,YR,223383532,1,HIV infection
22346881,223468811,1,I,,20230511,20230520,20230520,EXP,,KZ-HETERO-HET2023KZ01274,HETERO,,59,YR,,,Y,,,20230520,,HP,KZ,KZ,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Nephropathy toxic,223468811,OT,,,,,,,,,223468811,1,Asymptomatic HIV infection
22347410,223474101,1,I,20210124,20230515,20230521,20230521,EXP,,RU-009507513-2305RUS004835,MERCK,,,,,F,Y,78,KG,20230521,,MD,RU,RU,EFAVIRENZ,Diarrhoea;Headache;Pruritus;Rash,223474101,OT,,,223474101,1,20220208,20221228,324,DAY,223474101,1,HIV infection
22349614,223496141,1,I,,20230510,20230522,20230522,EXP,,IN-MACLEODS PHARMACEUTICALS US LTD-MAC2023041396,MACLEODS,"Choudhary S, Rangasamy K , Naidu S, Sachdeva RK , Sharma A. Subtrochanteric Pathological Femur Fracture in an HIV-Positive Patient on Tenofovir-based antiretroviral therapy: A Case Report and Review of the Literature. Journal of Orthopaedic Case Reports. 2023;13(2):14-20",,,,,Y,,,20230522,,MD,IN,IN,EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE,Anaemia;Femur fracture;Osteomalacia,223496141,HO,,,223496141,1,,,6,YR,223496141,1,Antiretroviral therapy
22349713,223497131,1,I,,20230510,20230522,20230522,EXP,,IT-MACLEODS PHARMACEUTICALS US LTD-MAC2023041403,MACLEODS,"Di Biagio A, Rosso R, Monteforte P, Russo R, Rovetta G, Viscoli C. Whole body bone scintigraphy in tenofovir-related osteomalacia: a case report. Journal of Medical Case Reports.. 2009;3:8136",,,,,Y,,,20230522,,HP,IT,IT,EFAVIRENZ,Fanconi syndrome;Hypophosphataemic osteomalacia,223497131,HO,,,223497131,1,200402,,,,223497131,1,HIV infection
22350512,223505121,1,I,,20230516,20230522,20230522,EXP,,GB-MYLANLABS-2023M1042673,MYLAN,,52,YR,,M,Y,,,20230522,,MD,GB,GB,EFAVIRENZ,Drug interaction;Nervous system disorder,223505121,OT,,,223505121,1,2008,,,,223505121,1,HIV infection
22355223,223552231,1,I,,20230515,20230523,20230523,EXP,,VN-MYLANLABS-2023M1051611,MYLAN,"Pham, D T; Truong, D T.. THE REDUCTION OF DRUG-INDUCED GYNECOMASTIA IN HIV-POSITIVE ADULT MAN: A CASE REPORT. JOURNAL OF MEDICAL RESEARCH. 2023;165 (4)",25,YR,,M,Y,53,KG,20230523,,HP,VN,VN,EFAVIRENZ,Gynaecomastia,223552231,OT,,,,,,,,,223552231,1,HIV infection
22356213,223562132,2,F,20230101,20230517,20230523,20230524,EXP,,AR-009507513-2305ARG006540,MERCK,,,,,M,Y,,,20230524,,CN,AR,AR,EFAVIRENZ,Abnormal dreams;Anxiety;Arrhythmia;Fear;Nervous system disorder;Therapeutic product effect incomplete;Therapy change,223562132,OT,,,223562132,1,2008,202302,,,223562132,1,HIV infection
22359677,223596771,1,I,,20220822,20230524,20230524,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2022-094585,BRISTOL MYERS SQUIBB,"Calcagno A, Celani L, Trunfio M, Orofino G, Imperiale D, Atzori C. et al. Alzheimer dementia in people living with HIV. Neurology: Clinical Practice. 2021 Oct; 11(5): e627-33. 10.1212/CPJ.0000000000001060",71,YR,E,M,Y,,,20230524,,MD,IT,IT,EFAVIRENZ,Dementia Alzheimer's type,223596771,OT,,,,,,,,,223596771,1,HIV infection
22370029,223700291,1,I,,20230515,20230526,20230526,EXP,,TZ-AUROBINDO-AUR-APL-2023-037867,AUROBINDO,"Mandari S, Aslan S, Deodatus S, Nyundo A.. Delusional Infestation: A case of Ekbom syndrome in an elderly woman with a long history of HIV. Clinical Case Reports. 2023;11(3):1-4",70,YR,,F,Y,,,20230526,,HP,TZ,TZ,EFAVIRENZ,Delusion of parasitosis,223700291,OT,,,,,,,,,223700291,1,HIV infection
22370972,223709721,1,I,,20230516,20230526,20230526,EXP,,GB-AUROBINDO-AUR-APL-2023-032577,AUROBINDO,,52,YR,,M,Y,,,20230526,,MD,GB,GB,EFAVIRENZ,Drug interaction;Nervous system disorder,223709721,OT,,,223709721,1,2008,,,,223709721,1,HIV infection
22372054,223720541,1,I,,20230519,20230526,20230526,EXP,,IN-MYLANLABS-2023M1054860,MYLAN,"Joseph A, Cherian KE, Kapoor N, Paul TV. Tenofovir-induced hypophosphatemic osteomalacia: how do bone mineral density, trabecular bone score and proximal hip geometry change with treatment?. Endocrinol-Diabetes-Metab-Case-Rep 2023;2023:No. 1.",46,YR,,F,Y,,,20230526,,HP,IN,IN,EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE,Glycosuria;Hypokalaemia;Hypophosphataemic osteomalacia;Hypouricaemia;Metabolic acidosis;Osteopenia;Osteoporosis;Renal tubular acidosis,223720541,OT,,,,,,,,,223720541,1,HIV infection
22373399,223733992,2,F,,20230528,20230526,20230602,EXP,,GB-MYLANLABS-2023M1044973,MYLAN,,,,,M,Y,,,20230602,,MD,GB,GB,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Agitation;Diabetes mellitus;Insomnia;Weight increased,223733992,OT,,,223733992,1,2013,,2920,DAY,223733992,1,HIV infection
22381016,223810161,1,I,,20230516,20230530,20230530,EXP,,GB-MACLEODS PHARMA EU LTD-MAC2023041052,MACLEODS,,,,,,Y,,,20230529,,MD,GB,GB,EFAVIRENZ,Drug interaction;Nervous system disorder,223810161,OT,,,223810161,1,2008,,,,223810161,1,HIV infection
22383335,223833352,2,F,,20230602,20230530,20230612,EXP,,IT-PFIZER INC-2002050690,PFIZER,,33,YR,,F,Y,,,20230612,,MD,IT,IT,EFAVIRENZ,Maternal exposure during pregnancy;Unevaluable event,223833352,OT,,,223833352,2,20000112,20000217,37,DAY,223833352,1,HIV infection
22384819,223848191,1,I,,20230529,20230530,20230530,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-2023-075568,BRISTOL MYERS SQUIBB,"Oliveira A, Taylor C, Agarwal K, Childs K. First description of efavirenz as a cause of drug-induced autoimmune hepatitis: compelling evidence from two cases. HIV Medicine. 2023 Apr 01;24(Supplement 3):61-2. doi:10.1111/hiv.13478.",33,YR,A,F,Y,,,20230530,,HP,GB,GB,EFAVIRENZ,Autoimmune hepatitis,223848191,OT,,,223848191,1,202004,202206,26,MON,223848191,1,HIV infection
22385851,223858511,1,I,,20230523,20230530,20230530,EXP,,CH-VIIV HEALTHCARE LIMITED-CH2023GSK073019,VIIV,"Erba A, Marzolini C, Rentsch K, Stoeckle M, Battegay M, Mayr M et al. Switch from a ritonavir to a cobicistat containing antiretroviral regimen and impact on tacrolimus levels in a kidney transplant recipient. Virology Journal. 2023;20 (1)",,,,,Y,,,20230530,,HP,CH,CH,EFAVIRENZ,Drug resistance;HIV viraemia;Pathogen resistance;Viral mutation identified,223858511,OT,,,223858511,6,1997,,,,223858511,1,HIV infection
22385852,223858521,1,I,,20230523,20230530,20230530,EXP,,CH-GSK-CH2023GSK073019,GLAXOSMITHKLINE,"Erba A, Marzolini C, Rentsch K, Stoeckle M, Battegay M, Mayr M et al. Switch from a ritonavir to a cobicistat containing antiretroviral regimen and impact on tacrolimus levels in a kidney transplant recipient. Virology Journal. 2023;20 (1)",,,,,Y,,,20230530,,HP,CH,CH,EFAVIRENZ,Drug resistance;HIV viraemia;Pathogen resistance;Viral mutation identified,223858521,OT,,,223858521,6,1997,,,,223858521,1,HIV infection
22386446,223864461,1,I,20221129,20230521,20230531,20230531,EXP,,GB-AUROBINDO-AUR-APL-2022-055907,AUROBINDO,,,,A,M,Y,,,20230531,,HP,GB,GB,EFAVIRENZ,Death,223864461,DE,,,,,,,,,223864461,1,HIV infection
22389441,223894412,2,F,,20230602,20230531,20230612,EXP,,IT-PFIZER INC-039-1343-M0200001,PFIZER,"FUNDARO, C.. MYELOMENINGOCELE IN A CHILD WITH INTRAUTERINE EXPOSURE TO EFAVIRENZ. AIDS. 2001;16(2):299-300",24,WK,,M,Y,3.45,KG,20230612,,MD,IT,IT,SUSTIVA,HIV test positive;Hydrocephalus;Maternal exposure during pregnancy;Meningomyelocele,223894412,CA,,,223894412,2,20000112,20000217,37,DAY,223894412,1,HIV infection
22390441,223904412,2,F,20170901,20230525,20230531,20230601,EXP,,PT-MYLANLABS-2023M1055358,MYLAN,,47,YR,,M,Y,,,20230601,,MD,PT,PT,EFAVIRENZ,Hyperphosphaturia;Hypertriglyceridaemia;Perforated ulcer;Proteinuria,223904412,OT,,,223904412,1,201308,,,,223904412,1,HIV infection
22391768,223917682,2,F,,20230528,20230601,20230610,EXP,,GB-MACLEODS PHARMA EU LTD-MAC2023041169,MACLEODS,,,,,,Y,,,20230609,,MD,GB,GB,EFAVIRENZ,Agitation;Diabetes mellitus;Insomnia;Weight increased,223917682,OT,,,223917682,1,2013,,,,223917682,1,HIV infection
22399171,223991711,1,I,,20230525,20230602,20230602,EXP,,UY-GSK-UY2023GSK077550,GLAXOSMITHKLINE,"Gonzalez Castro AV, Sande V, Pardo Casaretto LV, Gutierrez Rodriguez SI. Resistance to integrase inhibitors in children with vertically-transmitted human immunodeficiency virus: First cases in Uruguay. Archivos Argentinos De Pediatria. 2023",,,,,Y,,,20230602,,HP,UY,UY,EFAVIRENZ,Drug interaction;Pathogen resistance;Viral mutation identified;Virologic failure,223991711,OT,,,,,,,,,223991711,1,HIV infection
22399172,223991721,1,I,,20230525,20230602,20230602,EXP,,UY-VIIV HEALTHCARE LIMITED-UY2023GSK077550,VIIV,"Gonzalez Castro AV, Sande V, Pardo Casaretto LV, Gutierrez Rodriguez SI. Resistance to integrase inhibitors in children with vertically-transmitted human immunodeficiency virus: First cases in Uruguay. Archivos Argentinos De Pediatria. 2023",,,,,Y,,,20230602,,HP,UY,UY,EFAVIRENZ,Drug interaction;Pathogen resistance;Viral mutation identified;Virologic failure,223991721,OT,,,,,,,,,223991721,1,HIV infection
22399604,223996041,1,I,,20230525,20230602,20230602,EXP,,UY-GSK-UY2023GSK077527,GLAXOSMITHKLINE,"Gonzalez Castro AV, Sande V, Pardo Casaretto LV, Gutierrez Rodriguez SI. Resistance to integrase inhibitors in children with vertically-transmitted human immunodeficiency virus: First cases in Uruguay. Archivos Argentinos De Pediatria. 2023",,,,,Y,,,20230602,,HP,UY,UY,EFAVIRENZ,Pathogen resistance;Virologic failure,223996041,OT,,,,,,,,,223996041,1,HIV infection
22399605,223996051,1,I,,20230525,20230602,20230602,EXP,,UY-VIIV HEALTHCARE LIMITED-UY2023GSK077527,VIIV,"Gonzalez Castro AV, Sande V, Pardo Casaretto LV, Gutierrez Rodriguez SI. Resistance to integrase inhibitors in children with vertically-transmitted human immunodeficiency virus: First cases in Uruguay. Archivos Argentinos De Pediatria. 2023",,,,,Y,,,20230602,,HP,UY,UY,EFAVIRENZ,Pathogen resistance;Virologic failure,223996051,OT,,,,,,,,,223996051,1,HIV infection
22517361,225173611,1,I,,20230523,20230603,20230603,EXP,,ZA-AUROBINDO-AUR-APL-2023-029518,AUROBINDO,"Munsami L, Schutte CM, de Villiers M, Hiesgen J.. Late-onset efavirenz toxicity: A descriptive study from Pretoria, South Africa. South-Afr-J-HIV-Med. 2023;24No. 1.:1-6",,,A,,Y,,,20230603,,HP,ZA,ZA,EFAVIRENZ,Encephalopathy;Quadriparesis;Toxicity to various agents,225173611,OT,,,,,,,,,225173611,1,HIV infection
22517365,225173651,1,I,,20230523,20230603,20230603,EXP,,ZA-AUROBINDO-AUR-APL-2023-029519,AUROBINDO,"Munsami L, Schutte CM, de Villiers M, Hiesgen J.. Late-onset efavirenz toxicity: A descriptive study from Pretoria, South Africa. South-Afr-J-HIV-Med. 2023;24No. 1:1-6",,,A,,Y,,,20230603,,HP,ZA,ZA,EFAVIRENZ,Cerebellar ataxia;Hemiparesis;Toxicity to various agents,225173651,OT,,,,,,,,,225173651,1,HIV infection
22519477,225194771,1,I,,20230524,20230605,20230605,EXP,,IN-AUROBINDO-AUR-APL-2023-039662,AUROBINDO,,,,I,,Y,,,20230605,,HP,IN,IN,EFAVIRENZ,Foetal exposure during delivery;Neural tube defect,225194771,OT,,,,,,,,,225194771,1,Product used for unknown indication
22525100,225251002,2,F,,20230528,20230606,20230607,EXP,,GB-AUROBINDO-AUR-APL-2023-034068,AUROBINDO,,,,,M,Y,,,20230607,,MD,GB,GB,EFAVIRENZ,Agitation;Diabetes mellitus;Insomnia;Weight increased,225251002,OT,,,225251002,1,2013,2013,2920,DAY,225251002,1,HIV infection
22525206,225252061,1,I,,20230529,20230606,20230606,EXP,,FR-MYLANLABS-2023M1059146,MYLAN,"Kherabi Y, de Castro N, Sellier PO, Hamet G, Brun A, Mechai F, et al. Efficacy and Safety of Efavirenz, Raltegravir, and Dolutegravir in HIV-1/TB Coinfection. A Multicenter Retrospective Cohort Study in France. J-Acquir-Immune-Defic-Syndr 2022;91(1):85-90.",,,,,Y,,,20230606,,HP,FR,FR,EFAVIRENZ,Virologic failure,225252061,OT,,,,,,,,,225252061,1,Antiretroviral therapy
22525207,225252071,1,I,,20230529,20230606,20230606,EXP,,FR-MYLANLABS-2023M1059114,MYLAN,"Kherabi Y, de Castro N, Sellier PO, Hamet G, Brun A, Mechai F, et al. Efficacy and Safety of Efavirenz, Raltegravir, and Dolutegravir in HIV-1/TB Coinfection. A Multicenter Retrospective Cohort Study in France. J-Acquir-Immune-Defic-Syndr 2022;91(1):85-90.",,,,,Y,,,20230606,,HP,FR,FR,EFAVIRENZ,Virologic failure,225252071,OT,,,,,,,,,225252071,1,Antiretroviral therapy
22525208,225252081,1,I,,20230529,20230606,20230606,EXP,,FR-MYLANLABS-2023M1059145,MYLAN,"Kherabi Y, de Castro N, Sellier PO, Hamet G, Brun A, Mechai F, et al. Efficacy and Safety of Efavirenz, Raltegravir, and Dolutegravir in HIV-1/TB Coinfection. A Multicenter Retrospective Cohort Study in France. J-Acquir-Immune-Defic-Syndr 2022;91(1):85-90.",,,,,Y,,,20230606,,HP,FR,FR,EFAVIRENZ,Virologic failure,225252081,OT,,,,,,,,,225252081,1,Antiretroviral therapy
22525212,225252121,1,I,,20230529,20230606,20230606,EXP,,FR-MYLANLABS-2023M1059066,MYLAN,"Kherabi Y, de Castro N, Sellier PO, Hamet G, Brun A, Mechai F, et al. Efficacy and Safety of Efavirenz, Raltegravir, and Dolutegravir in HIV-1/TB Coinfection. A Multicenter Retrospective Cohort Study in France. J-Acquir-Immune-Defic-Syndr 2022;91(1):85-90.",,,,,Y,,,20230606,,HP,FR,FR,EFAVIRENZ,Virologic failure,225252121,OT,,,,,,,,,225252121,1,Antiretroviral therapy
22525300,225253001,1,I,,20230529,20230606,20230606,EXP,,FR-MYLANLABS-2023M1059060,MYLAN,"Kherabi Y, de Castro N, Sellier PO, Hamet G, Brun A, Mechai F, et al. Efficacy and Safety of Efavirenz, Raltegravir, and Dolutegravir in HIV-1/TB Coinfection. A Multicenter Retrospective Cohort Study in France. J-Acquir-Immune-Defic-Syndr 2022;91(1):85-90.",,,,,Y,,,20230606,,HP,FR,FR,EFAVIRENZ,Virologic failure,225253001,OT,,,,,,,,,225253001,1,Antiretroviral therapy
22526709,225267091,1,I,,20230531,20230606,20230606,EXP,,ZA-MYLANLABS-2023M1059226,MYLAN,"Maponga TG, Jeffries M, Tegally H, Sutherland A, Wilkinson E, Lessells RJ, et al. Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection With accumulation of mutations in a patient with poorly controlled Human Immunodeficiency Virus infection. Clin-Infect-Dis 2023;76(3):E522-E525.",22,YR,,F,Y,,,20230606,,HP,ZA,ZA,EFAVIRENZ,Intentional product misuse;Treatment noncompliance,225267091,OT,,,,,,,,,225267091,1,HIV infection
22529946,225299461,1,I,,20230531,20230607,20230607,EXP,,IT-JNJFOC-20230611912,JOHNSON AND JOHNSON,,71,YR,E,M,Y,,,20230607,,HP,IT,IT,EFAVIRENZ,Dementia Alzheimer's type,225299461,OT,,,,,,,,,225299461,1,HIV infection
22532673,225326731,1,I,20131001,20200226,20230607,20230607,EXP,,NVSC2020GB056080,NOVARTIS,"Kanellopoulos A, Kaparou M, Xenou E, Paneesha S, Kishore B, Lovell R et al.. Graft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplantat in HIV-infected patient with acute myeloid leukaemia. BONE MARROW TRANSPLANTATION. 2018;53(12):1518-21",39,YR,,M,Y,,,20230607,,HP,GB,GB,EFAVIRENZ,Acute myeloid leukaemia;Product use in unapproved indication,225326731,HO,,,225326731,4,200308,200311,3,MON,225326731,1,HIV infection CDC category C
22533286,225332861,1,I,20210901,20230531,20230607,20230607,EXP,,ZA-STRIDES ARCOLAB LIMITED-2023SP009080,STRIDES,"Maponga TG, Jeffries M, Tegally H, Sutherland A, Wilkinson E, Lessells RJ, et al.. Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection With accumulation of mutations in a patient with poorly controlled Human Immunodeficiency Virus infection.. Clin-Infect-Dis.. 2023;76(3):E522-E525.",22,YR,,F,Y,,,20230608,,HP,ZA,ZA,EFAVIRENZ,Intentional product misuse;Treatment noncompliance,225332861,OT,,,225332861,2,202109,,,,225332861,1,HIV infection
22533818,225338181,1,I,20180112,20230602,20230608,20230608,EXP,GB-EMA-DD-20190508-sahu_k-153427,GB-ABBVIE-5276400,ABBVIE,,,,,,Y,,,20230608,,HP,GB,GB,EFAVIRENZ,Cleft lip and palate;Drug abuse;Hydrops foetalis;Trisomy 18;Ultrasound antenatal screen,225338181,CA,,,,,,,,,225338181,1,Maternal exposure timing unspecified
22539265,225392651,1,I,,20230531,20230609,20230609,EXP,,ZA-LUPIN HEALTHCARE (UK) LIMITED-2023-04385,LUPIN,,,,,,Y,,,20230609,,CN,ZA,ZA,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Illness,225392651,HO,,,,,,,,,225392651,1,Epilepsy
22587671,225876711,1,I,,20230529,20230612,20230612,EXP,,IN-AUROBINDO-AUR-APL-2023-041672,AUROBINDO,"Joseph A, Cherian KE, Kapoor N, Paul TV. Tenofovir-induced hypophosphatemic osteomalacia: how do bone mineral density, trabecular bone score and proximal hip geometry change with treatment?. Endocrinology Diabetes and Metabolism Case Reports. 2023",46,YR,,F,Y,,,20230612,,HP,IN,IN,EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL FUMARATE,Glycosuria;Hypokalaemia;Hypophosphataemic osteomalacia;Hypouricaemia;Renal tubular acidosis,225876711,OT,,,,,,,,,225876711,1,HIV infection
22590557,225905571,1,I,,20230603,20230612,20230612,EXP,,UG-GSK-UG2023080820,GLAXOSMITHKLINE,,,,,,Y,,,20230612,,MD,UG,UG,EFAVIRENZ,Hospitalisation,225905571,HO,,,225905571,1,20060705,,,,225905571,1,HIV infection
22590558,225905581,1,I,,20230603,20230612,20230612,EXP,,UG-VIIV HEALTHCARE LIMITED-UG2023080820,VIIV,,,,,,Y,,,20230612,,MD,UG,UG,EFAVIRENZ,Hospitalisation,225905581,HO,,,225905581,1,20060705,,,,225905581,1,HIV infection
22591196,225911961,1,I,,20230601,20230612,20230612,EXP,,IT-GSK-IT2023GSK079465,GLAXOSMITHKLINE,"Labate L, Bruzzone B, Spagnuolo V, Zazzi M, Santoro MM, Di Biagio A et al. Prestigio ring: ^A 59-year-old HIV-1 positive, highly treatment-experienced women failing darunavir/ritonavir plus raltegravir.^. The New Microbiologica. 2023;46(2):226-230",,,,,Y,,,20230612,,HP,IT,IT,EFAVIRENZ,Immune system disorder;Insomnia;Neuropathy peripheral;Pathogen resistance;Toxicity to various agents;Treatment failure;Treatment noncompliance;Viral mutation identified;Virologic failure,225911961,OT,,,225911961,1,19960711,19990505,1028,DAY,225911961,1,HIV infection
22591202,225912021,1,I,,20230601,20230612,20230612,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2023GSK079465,VIIV,"Labate L, Bruzzone B, Spagnuolo V, Zazzi M, Santoro MM, Di Biagio A et al. Prestigio ring: ^A 59-year-old HIV-1 positive, highly treatment-experienced women failing darunavir/ritonavir plus raltegravir.^. The New Microbiologica. 2023;46(2):226-230",,,,,Y,,,20230612,,HP,IT,IT,EFAVIRENZ,Immune system disorder;Insomnia;Neuropathy peripheral;Pathogen resistance;Toxicity to various agents;Treatment failure;Treatment noncompliance;Viral mutation identified;Virologic failure,225912021,OT,,,225912021,1,19960711,19990505,1028,DAY,225912021,1,HIV infection
22594443,225944431,1,I,,20230609,20230613,20230613,EXP,,JP-GILEAD-2023-0625705,GILEAD,,,,A,F,Y,,,20230613,,MD,JP,JP,EFAVIRENZ,Hypokalaemia,225944431,OT,,,225944431,1,201909,2012,,,225944431,1,Product used for unknown indication
22595211,225952111,1,I,,20230605,20230613,20230613,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2023GSK080298,VIIV,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422",,,,,Y,,,20230613,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,225952111,OT,,,,,,,,,225952111,1,HIV infection
22596572,225965721,1,I,,20230605,20230613,20230613,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2023GSK080574,VIIV,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422",,,,,Y,,,20230613,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,225965721,OT,,,,,,,,,225965721,1,HIV infection
22596597,225965971,1,I,,20230605,20230613,20230613,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2023GSK080599,VIIV,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422",,,,,Y,,,20230613,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,225965971,OT,,,,,,,,,225965971,1,HIV infection
22597265,225972651,1,I,,20230531,20230614,20230614,EXP,,CA-CIPLA LTD.-2023TZ03098,CIPLA,"Lopez A, Campbell L, Bacha J, Kovarik C.. Successful use of multidisciplinary palliative care in the outpatient treatment of disseminated histoplasmosis in an HIV positive child. Children. 2021;8:1 to 10",,,,,Y,,,20230614,,HP,CA,TZ,EFAVIRENZ,Histoplasmosis;Treatment failure,225972651,HO,,,,,,,,,225972651,1,Antiretroviral therapy
22599581,225995812,2,F,20201101,20230622,20230614,20230627,EXP,,TH-ORGANON-O2306THA001548,ORGANON,,24,YR,,F,Y,,,20230627,,HP,TH,TH,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Inappropriate schedule of product administration;Pregnancy with implant contraceptive;Unintended pregnancy,225995812,OT,,,225995812,1,202011,,,,225995812,2,HIV infection
22601077,226010772,2,F,20200224,20230622,20230614,20230627,EXP,,TH-ORGANON-O2306THA001559,ORGANON,,18,YR,,F,Y,,,20230627,,HP,TH,TH,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Abortion induced;Inappropriate schedule of product administration;Pregnancy with implant contraceptive;Unintended pregnancy,226010772,OT,,,226010772,1,20200224,,,,226010772,2,HIV infection
22602945,226029451,1,I,,20230601,20230615,20230615,EXP,,IN-MACLEODS PHARMA EU LTD-MAC2023041836,MACLEODS,"Subith S, Tungenwar S, Avhad T, Apte T, Dakhode S. Anti-retroviral Therapy-Induced Multiple Pathological Fractures in a HIV-Positive Young Female: A Case Report and Review of Literature. Journal of Orthopaedic Case Reports. 2023;13(5):111-115",,,,,Y,,,20230614,,MD,IN,IN,EFAVIRENZ,Femur fracture;Fibula fracture;Forearm fracture;Metabolic acidosis;Osteopenia;Osteoporosis,226029451,HO,,,,,,,,,226029451,1,Retroviral infection
22603892,226038921,1,I,,20230604,20230615,20230615,EXP,,IN-HETERO-HET2023IN01158,HETERO,"Subith S, Tungenwar S, Avhad T, Apte T, Dakhode S.. Anti-retroviral Therapy-Induced Multiple Pathological Fractures in a  HIV-Positive Young Female: A Case Report and Review of Literature. Journal of Orthopaedic Case Reports.. 2023;13(5):111",38,YR,,F,Y,,,20230615,,MD,IN,IN,EFAVIRENZ,Multiple fractures;Osteoporosis;Pathological fracture,226038921,OT,,,,,,,,,226038921,1,HIV infection
22605939,226059391,1,I,,20230605,20230615,20230615,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2023GSK081824,VIIV,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422",,,,,Y,,,20230615,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226059391,OT,,,,,,,,,226059391,1,HIV infection
22606090,226060901,1,I,,20230605,20230615,20230615,EXP,,IT-GSK-IT2023GSK080786,GLAXOSMITHKLINE,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422",,,,,Y,,,20230615,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226060901,OT,,,,,,,,,226060901,1,HIV infection
22606091,226060911,1,I,,20230605,20230615,20230615,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2023GSK080786,VIIV,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422",,,,,Y,,,20230615,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226060911,OT,,,,,,,,,226060911,1,HIV infection
22608597,226085971,1,I,,20230607,20230616,20230616,EXP,,CH-STRIDES ARCOLAB LIMITED-2023SP009479,STRIDES,"Erba A, Marzolini C, Rentsch K, Stoeckle M, Battegay M, Mayr M, et al. Switch from a ritonavir to a cobicistat containing antiretroviral regimen and impact on tacrolimus levels in a kidney transplant recipient. Virol-J. 2023;20(1)",5,DEC,,M,Y,,,20230616,,HP,CH,CH,EFAVIRENZ,Diabetes mellitus;Diabetic foot infection;Drug interaction;Drug level decreased;Drug level increased;Drug resistance;Erysipelas;Neuropathy peripheral;Peripheral arterial occlusive disease,226085971,OT,,,,,,,,,226085971,1,HIV infection
22610097,226100971,1,I,,20230605,20230616,20230616,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2023GSK080716,VIIV,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422",,,,,Y,,,20230616,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226100971,OT,,,,,,,,,226100971,1,HIV infection
22610860,226108601,1,I,,20230605,20230616,20230616,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2023GSK080739,VIIV,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422",,,,,Y,,,20230616,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226108601,OT,,,,,,,,,226108601,1,HIV infection
22611023,226110231,1,I,,20230605,20230616,20230616,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2023GSK080779,VIIV,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422",,,,,Y,,,20230616,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226110231,OT,,,,,,,,,226110231,1,HIV infection
22611239,226112391,1,I,,20230605,20230616,20230616,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2023GSK081378,VIIV,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422",,,,,Y,,,20230616,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226112391,OT,,,,,,,,,226112391,1,HIV infection
22611491,226114911,1,I,20120521,20230613,20230616,20230616,EXP,,"GB-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-178274",BOEHRINGER INGELHEIM,,3,MON,I,M,Y,,,20230616,,HP,GB,GB,EFAVIRENZ,Alanine aminotransferase increased;Aspartate aminotransferase increased;Cleft lip and palate;Foetal exposure during pregnancy;Hepatic cytolysis;Hydrops foetalis;Intentional product use issue;Off label use;Trisomy 18;Ultrasound antenatal screen,226114911,CA,,,226114911,1,20090101,20100610,525,DAY,226114911,1,Foetal exposure during pregnancy
22612470,226124701,1,I,,20230606,20230617,20230617,EXP,,ZA-AUROBINDO-AUR-APL-2023-030969,AUROBINDO,"Maharaj M, Levin M.. ADVERSE DRUG REACTIONS TO ANTIRETROVIRAL COMBINATION TREATMENTS IN A CHILD. Curr-All-Clinical-Immunol. 2022;35(3):180-181",4,YR,,F,Y,,,20230617,,HP,ZA,ZA,EFAVIRENZ,Drug hypersensitivity;Eosinophilia;Flushing;Pyrexia;Rash;Transaminases increased;Vomiting,226124701,OT,,,,,,,,,226124701,1,HIV infection
22614017,226140171,1,I,,20230607,20230619,20230619,EXP,,CA-AUROBINDO-AUR-APL-2023-041854,AUROBINDO,,44,YR,,M,Y,,,20230619,,HP,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor retardation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,226140171,HO,,,,,,,,,226140171,1,Psychotic disorder
22614164,226141641,1,I,,20230616,20230619,20230619,EXP,,"IT-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-244516",BOEHRINGER INGELHEIM,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422. doi:10.1093/jac/dkad101",,,A,,Y,,,20230619,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226141641,OT,,,,,,,,,226141641,1,HIV infection
22614402,226144021,1,I,,20230612,20230619,20230619,EXP,,MY-STRIDES ARCOLAB LIMITED-2023SP009585,STRIDES,"Chua KY, Tey KE.. Cutaneous adverse drug reactions among people living with human immunodeficiency virus in a tertiary care hospital in Johor, Malaysia.. Int-J-STD-AIDS. 2022;33(9):812-820.",,,,,Y,,,20230619,,HP,MY,MY,EFAVIRENZ,Photodermatosis,226144021,OT,,,,,,,,,226144021,1,HIV infection
22614420,226144201,1,I,,20230612,20230619,20230619,EXP,,MY-STRIDES ARCOLAB LIMITED-2023SP009542,STRIDES,"Chua KY, Tey KE.. Cutaneous adverse drug reactions among people living with human immunodeficiency virus in a tertiary care hospital in Johor, Malaysia.. Int-J-STD-AIDS.. 2022;33(9):812-820",,,,,Y,,,20230619,,HP,MY,MY,EFAVIRENZ,Angioedema,226144201,OT,,,,,,,,,226144201,1,HIV infection
22614583,226145831,1,I,,20230608,20230619,20230619,EXP,,FR-AUROBINDO-AUR-APL-2022-036099,AUROBINDO,"Kherabi Y, de Castro N, Sellier P, Hamet G, Brun A, Mecha? F et al. Brief Report: Efficacy and Safety of Efavirenz, Raltegravir, and Dolutegravir in HIV-1/TB Coinfection. A Multicenter Retrospective Cohort Study in France. Journal of acquired immune deficiency syndromes. 2022;91(1):85-90",,,A,,Y,,,20230619,,HP,FR,FR,EFAVIRENZ,Virologic failure,226145831,OT,,,,,,,,,226145831,1,HIV infection
22615007,226150071,1,I,,20230616,20230619,20230619,EXP,,"IT-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-244515",BOEHRINGER INGELHEIM,,,,A,,Y,,,20230619,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226150071,OT,,,,,,,,,226150071,1,HIV infection
22615020,226150201,1,I,,20230616,20230619,20230619,EXP,,"IT-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-244517",BOEHRINGER INGELHEIM,,,,A,,Y,,,20230619,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226150201,OT,,,,,,,,,226150201,1,HIV infection
22615086,226150861,1,I,,20230616,20230619,20230619,EXP,,"IT-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-244513",BOEHRINGER INGELHEIM,,,,A,,Y,,,20230619,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226150861,OT,,,,,,,,,226150861,1,HIV infection
22616479,226164791,1,I,,20230605,20230619,20230619,EXP,,IT-VIIV HEALTHCARE LIMITED-IT2023GSK081308,VIIV,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422",,,,,Y,,,20230619,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226164791,OT,,,,,,,,,226164791,1,HIV infection
22616877,226168771,1,I,20230101,20230616,20230619,20230619,EXP,,CN-ABBVIE-5294044,ABBVIE,,52,YR,,M,Y,53,KG,20230619,,MD,CN,CN,EFAVIRENZ,Adverse drug reaction;Decreased appetite;Dizziness;Hyperlipidaemia,226168771,OT,,,226168771,1,20230201,20230410,69,DAY,226168771,1,Antiviral treatment
22617714,226177141,1,I,,20230524,20230620,20230620,PER,,US-APOTEX-2022AP016966,APOTEX,,45,YR,,F,Y,,,20230620,,HP,US,US,EFAVIRENZ,Maternal exposure during pregnancy;No adverse event,,,,,,,,,,,226177141,1,Antiretroviral therapy
22620007,226200071,1,I,,20230616,20230620,20230620,EXP,,"IT-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-244507",BOEHRINGER INGELHEIM,,,,A,,Y,,,20230620,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226200071,OT,,,,,,,,,226200071,1,HIV infection
22620702,226207021,1,I,20230415,20230620,20230620,20230620,EXP,,GB-GILEAD-2023-0633485,GILEAD,,,,A,M,Y,,,20230620,,HP,GB,GB,EFAVIRENZ,Death,226207021,DE,,,,,,,,,226207021,1,Product used for unknown indication
22620756,226207561,1,I,,20230613,20230620,20230620,EXP,,MY-MYLANLABS-2023M1063215,MYLAN,,34,YR,,M,Y,,,20230620,,PH,MY,MY,EFAVIRENZ,Headache;Mouth ulceration;Pyrexia;Rash;Somnolence,226207561,OT,,,,,,,,,226207561,1,Antiretroviral therapy
22624037,226240371,1,I,,20230614,20230621,20230621,EXP,,CO-MYLANLABS-2023M1064659,MYLAN,"Urbano-Alban DC, Orozco-Burbano JD, Andrade-Eraso AF, Cabrera-Velasco CE, Lozano-Fernandez VH. Strongyloides stercoralis in the bone marrow of a person living with HIV: Case report. [Spanish]. Iatreia 2022;35(4):475-479.",30,YR,,M,Y,,,20230621,,HP,CO,CO,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Drug ineffective,226240371,DE,,,,,,,,,226240371,1,Antiretroviral therapy
22625269,226252691,1,I,,20230616,20230621,20230621,EXP,,"IT-B.I. Pharmaceuticals,Inc./Ridgefield-2023-BI-244526",BOEHRINGER INGELHEIM,,,,A,,Y,,,20230621,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226252691,OT,,,,,,,,,226252691,1,HIV infection
22628043,226280431,1,I,,20230616,20230622,20230622,EXP,,IT-JNJFOC-20230641963,JOHNSON AND JOHNSON,,,,A,,Y,,,20230622,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226280431,OT,,,,,,,,,226280431,1,HIV infection
22628226,226282261,1,I,,20230621,20230622,20230622,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-2023-087743,BRISTOL MYERS SQUIBB,,,,,F,Y,,,20230622,,HP,GB,GB,EFAVIRENZ,Neurotoxicity,226282261,OT,,,,,,,,,226282261,1,Product used for unknown indication
22628900,226289002,2,F,,20230616,20230622,20230630,EXP,,IT-JNJFOC-20230642011,JOHNSON AND JOHNSON,,,,A,,Y,,,20230630,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226289002,OT,,,,,,,,,226289002,1,HIV infection
22631201,226312011,1,I,,20230614,20230623,20230623,EXP,,CO-STRIDES ARCOLAB LIMITED-2023SP009704,STRIDES,"Urbano-Alban DC, Orozco-Burbano JD, Andrade-Eraso AF, Cabrera-Velasco CE, Lozano-Fernandez VH.. Strongyloides stercoralis in the bone marrow of a person living with HIV: Case report. [Spanish].. Iatreia. 2022;35(4):475-479.",30,YR,,M,Y,,,20230623,,HP,CO,CO,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Drug ineffective;Septic shock,226312011,HO,,,,,,,,,226312011,1,Diffuse large B-cell lymphoma
22633180,226331802,2,F,,20230616,20230623,20230630,EXP,,IT-JNJFOC-20230641762,JOHNSON AND JOHNSON,,,,A,,Y,,,20230630,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226331802,OT,,,,,,,,,226331802,1,HIV infection
22633993,226339931,1,I,,20230619,20230623,20230623,EXP,,IT-ROCHE-3371846,ROCHE,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings. The Journal of antimicrobial chemotherapy. doi:10.1093/jac/dkad101 2023;78(6):1415-1422.",,,A,,Y,,,20230623,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226339931,OT,,,,,,,,,226339931,1,HIV infection
22634163,226341631,1,I,20230617,,20230622,20230622,DIR,664410,,FDA-CTU,,51,YR,,M,N,80.1,KG,20230622,Y,CN,US,,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Dizziness;Dyspnoea;Flushing;Hyperhidrosis;Nausea;Performance fear,,,226341631,CSM,226341631,1,20230617,20230618,,,,,
22635155,226351551,1,I,,20230621,20230623,20230623,EXP,,GB-GILEAD-2023-0633802,GILEAD,,,,,F,Y,,,20230623,,HP,GB,GB,EFAVIRENZ,Neurotoxicity,226351551,OT,,,,,,,,,226351551,1,Product used for unknown indication
22635354,226353541,1,I,20230415,20230620,20230623,20230623,EXP,,GB-MYLANLABS-2023M1065474,MYLAN,,,,,M,Y,,,20230623,,HP,GB,GB,EFAVIRENZ,Death,226353541,DE,,,,,,,,,226353541,1,HIV infection
22638289,226382891,1,I,,20230619,20230626,20230626,EXP,,IT-ROCHE-3371844,ROCHE,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings.. The Journal of antimicrobial chemotherapy 2023;78(6):1415-1422.",,,A,,Y,,,20230624,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226382891,OT,,,,,,,,,226382891,1,HIV infection
22639017,226390171,1,I,,20230619,20230626,20230626,EXP,,IT-ROCHE-3371830,ROCHE,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings.. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422.",,,A,,Y,,,20230626,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226390171,OT,,,,,,,,,226390171,1,HIV infection
22639410,226394101,1,I,,20230614,20230626,20230626,EXP,,IT-AUROBINDO-AUR-APL-2023-043610,AUROBINDO,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al.. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings.. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422",,,A,,Y,,,20230626,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226394101,OT,,,,,,,,,226394101,1,HIV infection
22639426,226394261,1,I,,20230614,20230626,20230626,EXP,,IT-AUROBINDO-AUR-APL-2023-043613,AUROBINDO,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al.. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings. The Journal of antimicrobial chemotherapy. 2023;1415-1422:78(6)",,,A,,Y,,,20230626,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226394261,OT,,,,,,,,,226394261,1,HIV infection
22639531,226395311,1,I,,20230614,20230626,20230626,EXP,,IT-AUROBINDO-AUR-APL-2023-043201,AUROBINDO,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al.. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings.. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422",,,A,,Y,,,20230626,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226395311,OT,,,,,,,,,226395311,1,HIV infection
22641024,226410241,1,I,20230415,20230622,20230626,20230626,EXP,,GB-MYLANLABS-2023M1066658,MYLAN,,,,A,M,Y,,,20230626,,HP,GB,GB,EFAVIRENZ,Death,226410241,DE,,,,,,,,,226410241,1,Product used for unknown indication
22641965,226419651,1,I,20210901,20230615,20230626,20230626,EXP,,CN-VIIV HEALTHCARE LIMITED-CN2023APC084075,VIIV,,,,,,Y,,,20230626,,MD,CN,CN,EFAVIRENZ,Abdominal pain upper;Depression;Diarrhoea;Fatigue;Heart rate decreased;Hepatic failure;Non-alcoholic fatty liver;Tongue coated;Toxicity to various agents,226419651,OT,,,,,,,,,226419651,1,HIV infection
22641971,226419711,1,I,20210901,20230615,20230626,20230626,EXP,,CN-GSK-CN2023APC084075,GLAXOSMITHKLINE,,,,,,Y,,,20230626,,MD,CN,CN,EFAVIRENZ,Abdominal pain upper;Depression;Diarrhoea;Fatigue;Heart rate decreased;Hepatic failure;Non-alcoholic fatty liver;Tongue coated;Toxicity to various agents,226419711,OT,,,,,,,,,226419711,1,HIV infection
22642348,226423481,1,I,,20230621,20230626,20230626,EXP,,US-GILEAD-2023-0634105,GILEAD,,,,A,M,Y,,,20230626,,HP,US,US,EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE,Back pain;Balance disorder;Candida infection;Depression;Fatigue;Hemiparesis;Mood swings;Neurosyphilis;Sensory disturbance;Transient ischaemic attack;Weight decreased,226423481,OT,,,,,,,,,226423481,1,HIV infection
22645314,226453141,1,I,,20230621,20230627,20230627,EXP,,GB-MYLANLABS-2023M1066298,MYLAN,,,,,F,Y,,,20230627,,HP,GB,GB,EFAVIRENZ,Neurotoxicity,226453141,OT,,,,,,,,,226453141,1,Product used for unknown indication
22646443,226464431,1,I,,20230621,20230627,20230627,EXP,,IT-MYLANLABS-2023M1066778,MYLAN,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422",,,A,,Y,,,20230627,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226464431,OT,,,,,,,,,226464431,1,HIV infection
22646473,226464731,1,I,,20230621,20230627,20230627,EXP,,IT-MYLANLABS-2023M1066729,MYLAN,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422",,,A,,Y,,,20230627,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226464731,OT,,,,,,,,,226464731,1,HIV infection
22646768,226467681,1,I,,20230621,20230627,20230627,EXP,,IT-MYLANLABS-2023M1066665,MYLAN,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al.. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings.. The Journal of antimicrobial chemotherapy.. 2023;78(6):1415-1422",,,A,,Y,,,20230627,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226467681,OT,,,,,,,,,226467681,1,HIV infection
22646769,226467691,1,I,,20230621,20230627,20230627,EXP,,IT-MYLANLABS-2023M1066656,MYLAN,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al.. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings.. The Journal of antimicrobial chemotherapy.. 2023;78(6):1415-1422",,,A,,Y,,,20230627,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226467691,OT,,,,,,,,,226467691,1,HIV infection
22646883,226468831,1,I,,20230621,20230627,20230627,EXP,,IT-MYLANLABS-2023M1066376,MYLAN,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings.. The Journal of antimicrobial chemotherapy. 2023;78(6):1415-1422",,,A,,Y,,,20230627,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226468831,OT,,,,,,,,,226468831,1,HIV infection
22646957,226469571,1,I,,20230621,20230627,20230627,EXP,,IT-MYLANLABS-2023M1066336,MYLAN,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings.. The Journal of antimicrobial chemotherapy.. 2023;78(6):1415-1422.",,,A,,Y,,,20230627,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226469571,OT,,,,,,,,,226469571,1,HIV infection
22646984,226469841,1,I,,20230621,20230627,20230627,EXP,,IT-MYLANLABS-2023M1066339,MYLAN,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al.. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings.. The Journal of antimicrobial chemotherapy.. 2023;78(6):1415-1422",,,A,,Y,,,20230627,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226469841,OT,,,,,,,,,226469841,1,HIV infection
22646990,226469901,1,I,,20230621,20230627,20230627,EXP,,IT-MYLANLABS-2023M1066296,MYLAN,"Armenia D, Santoro MM, Charpentier C, Bertoli A, Forbici F, Calvez V, et al.. Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings.. The Journal of antimicrobial chemotherapy.. 2023;78(6):1415-1422",,,A,,Y,,,20230627,,HP,IT,IT,EFAVIRENZ,Pathogen resistance;Treatment failure;Viral mutation identified;Virologic failure,226469901,OT,,,,,,,,,226469901,1,HIV infection
22651632,226516321,1,I,,20230622,20230628,20230628,EXP,,CA-MYLANLABS-2019M1132176,MYLAN,,54,YR,,M,Y,,,20230628,,HP,CA,CA,EFAVIRENZ;SUSTIVA,Depression;Labelled drug-drug interaction medication error;Psychiatric decompensation,226516321,OT,,,,,,,,,226516321,1,Product used for unknown indication
22651933,226519331,1,I,,20230626,20230628,20230628,EXP,,CA-BAUSCH-BL-2023-009724,BAUSCH AND LOMB,,54,YR,,M,Y,,,20230628,,HP,CA,CA,SUSTIVA,Anxiety;Depression suicidal;Depressive symptom;Paranoia;Psychiatric decompensation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,226519331,HO,,,,,,,,,226519331,1,Depression
22662018,226620181,1,I,20100922,20230622,20230630,20230630,EXP,,GB-009507513-1101GBR00090B1,MERCK,,0,YR,,F,Y,2.45,KG,20230630,,HP,GB,GB,EFAVIRENZ,Foetal exposure during pregnancy;Low birth weight baby,226620181,OT,,,226620181,1,20100922,,,,,,
6753908,675390819,19,F,20060602,20230419,20080911,20230424,EXP,,CA-MERCK-0809CAN00002,MERCK,"Harris M, Larsen G, Montaner JSG. Harris M, Larsen G, Montaner JSG. Exacerbation of depression associated with starting raltegravir: a report of four cases. AIDS. 2008;22 (14):1890-2. AIDS. 2008;22 (14):1890-2",44,YR,,M,Y,,,20230424,,MD,CA,CA,SUSTIVA,Anxiety;Depression;Depression suicidal;Depressive symptom;Drug interaction;Paranoia;Psychiatric decompensation;Psychomotor retardation;Psychomotor skills impaired;Psychotic disorder;Suicidal ideation;Tearfulness,675390819,HO,,,675390819,1,20070626,20070626,2,DAY,675390819,1,HIV infection
7609977,760997730,30,F,20061128,20230508,20100928,20230517,EXP,,JP-JNJFOC-20100907113,JOHNSON AND JOHNSON,,49,YR,A,M,Y,,,20230517,,MD,JP,JP,EFAVIRENZ,Anaemia;Drug resistance;Dyslipidaemia;Hepatocellular carcinoma;Hyperbilirubinaemia;Osteoporosis;Pyelonephritis,760997730,HO,,,760997730,1,20061111,20220927,12,YR,760997730,1,HIV infection
8879908,88799087,7,F,20110918,20230424,20121031,20230426,EXP,,JP-GILEAD-2012-0063774,GILEAD,,30,YR,A,M,Y,,,20230426,,MD,JP,JP,EFAVIRENZ,Gastritis;Gastrooesophageal reflux disease;Intentional overdose;Nicotine dependence;Seasonal allergy;Suicide attempt,88799087,LT,,,88799087,1,20110805,20110918,44,DAY,88799087,1,HIV infection
9438099,94380999,9,F,20070101,20230417,20130802,20230425,EXP,,AT-BRISTOL-MYERS SQUIBB COMPANY-18931295,BRISTOL MYERS SQUIBB,,,,,,Y,,,20230425,,HP,AT,AT,EFAVIRENZ,Neurotoxicity,94380999,OT,,,,,,,,,94380999,1,HIV infection
